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Exploring factors impacting veterans’ hypertension (HTN) control is essential in 
reducing the common cardiovascular disease event of stroke, heart attack, chronic kidney 
disease and mortality.  The purpose of this study was to describe multidimensional 
factors impacting veterans’ HTN control.  Utilizing a descriptive, exploratory, cross-
sectional, retrospective, convenience sampling research design, 331 electronic medical 
records in a VA dashboard data set were reviewed for men and women veterans between 
the age 24 and 98 years (M=62, SD=13) in a Southern California Veterans Affair 
primary care clinic from October 17, 2014 through October 17, 2016.  Data were 
analyzed by univariate, bivariate and multivariate statistics.  The study found that self-
reported medication adherence to antihypertensive drugs (p < .001) was an independent 
predictor to veterans’ final systolic blood pressure.   Future HTN control research may 
focus on some theory-guided multidimensional determinants of patients’ adherence to 
HTN treatments and HTN control outcomes fully, utilizing a consistent HTN definition 
defined by JNC-7.      
Keywords: factors impacting hypertension control, self-reported medication 
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Chapter 1: Overview 
Background and Rational 
Exploring factors impacting veterans’ hypertension (HTN) control is important in 
reducing common cardiovascular disease events of stroke, heart attack, chronic kidney 
disease and mortality.  Despite decades of efforts by government agencies, researchers, 
healthcare providers and patients to improve the rate of HTN control, it remains a major 
public health challenge in the United States.  Compared with a target HTN control goal of 
61.2% set by Healthy People 2020 (Gillespie & Hurvitz, 2013), the overall HTN control 
rate remains suboptimal at 51.8% (Nwankwo, Yoon, Burt, & Gu, 2013).  Reasons for the 
suboptimal HTN control rate are multifactorial and likely associated with the insufficient 
and or inaccurate description of predictive factors impacting HTN control.  Guided by the 
seventh report of the Joint National Committee on prevention, detection, evaluation, and 
treatment of high blood pressure (JNC-7, Chobanian et al., 2003), the purpose of this 
study was to describe multidimensional factors impacting veterans’ HTN control.   
Significance  
This study was significant for the nursing profession for a couple of reasons.  
First, the study added comprehensive new knowledge concerning the characteristics of 
hypertensive veterans in the Southern California region to the scholarly nursing research 
database.  Second, the finding of self-reported medication adherence as a predictor 
(p<0.001) may stimulate further nursing research toward exploring some theory-guided 





control outcomes fully, utilizing a consistent HTN definition defined by JNC-7 which 
may in turn, lead to an improved data collection, quality healthcare outcome and cost 
saving.  Third, the study offered many insights into conducting a retrospective analysis 
with a Veterans’ Affair (VA) dashboard data set in an EMR system that may help novice 
researchers with this approach in the future.  
Hypertension (HTN) Control Conceptual Framework 
The conceptual framework guiding the study design was based upon the JNC-7 
HTN management guideline (Chobanian et al., 2003).  Although this guideline 
approached the HTN-control challenge from four-domains (Domains 1 to 4, see Figure 
1), an additional domain was added to illustrate the conceptualization of the HTN-control 
issue within Domain 5 (see Figure 2).  As such, the HTN control conceptual framework 
consisted of five domains: prevention, detection, evaluation, treatment, and outcome.  
This study focused on the relationship between seven dimensional independent variables 
(IVs) and one dependent variable (DV) at a final point of EMR review within Domain 5.  
The seven dimensions were (a) socio-demographic (e.g., age, sex, race, religion, branch 
of military service, time of military service, education, disability rating, insurance/copay), 
(b) lifestyle (e.g., tobacco, alcohol, DASH, exercise, caffeine, stress), (c) secondary HTN 
(e.g., obstructive sleep apnea [OSA]), (d) comorbidity (e.g., diabetes mellitus [DM], 
dyslipidemia, obesity [BMI]), (e) mental health disorder (e.g., major depressive disorder 
[MDD], generalized anxiety disorder [GAD], post-traumatic stress disorder [PTSD]), (f) 
medication (e.g., effectiveness, adherence, number of primary and cardiology clinic 





of all medication), (g) uncontrolled HTN-associated end organ damage (e.g., cerebral 
vascular accident [CVA], transient ischemic attack [TIA], congestive heart failure [CHF], 
coronary artery disease [CAD], myocardial infarction [MI], coronary artery bypass graft 
[CABG], chronic kidney disease [CKD]).  This framework was used primarily for 
identifying key study variables and developing a standardized data collection instrument 





Figure 1. Hypertension (HTN) Control Conceptual Framework (5-domaine)  
2.    DETECTION: 
Secondary HTN 
OSA, drug-induced HTN,  
primary aldosteronism,  
renal artery stenosis,  
pheochromocytoma,  
coarctation of aorta,  
pulmonary hypertension 
4.    TREATMENT 
BP Goal <140/90 mmHg 
Advise lifestyle change, DASH 
Monotherapy for Stage 1 HTN: ACEI, 
ARB, BB, CCB  
or 
Combination-therapy for Stage 2 
HTN: thiazide diuretic & ACEI, ARB, 
BB, CCB  
or 
Compelling indicator- add other drug 
class   
LVH/CHF/MI/CAD/CABG, DM,  
CKD (GFR<60) ml/min, CVA/TIA 
Minority group 
Arrange weight reduction program 
1.    HTN PREVENTION:  
Stage-2 HTN f/u 2-4 x /yr.   
Assess lifestyle, fear or concern,     
V 15.81, med-effectiveness,  
clinical inertia, K+, Cr 1-2/yr., lipid, 
BS past 12-month 
Advise weight↓, DASH, smoke 
cessation, mod-alcohol, exercise 
3-4 days/week & 40’ per session,   
BP treatment & goal 
Arrange BP f/u appointment 
3.    EVALUATION: 
BP Categories: <120/80, 120-139/80-89,  
140-159/90-99, ≥160/100,  
White coat, resistant HTN, orthostatic  
hypotension 
BMI Categories: 25-29.9, 30-34.9,  
35-39.9, ≥ 40   
WC: male ≥40 ‘’, female ≥35” 
History: lifestyle, comorbidity, OSA,  
understanding, acceptance of HTN  
diagnosis, treatment plan commitment 
PE: brain (dementia, CVA, TIA); heart  
(CAD, MI, CABG, CHF); kidney (CKD); eye  
(retinopathy); CAD 
Lab: microalbuminuria, GFR<60  
5.    HTN CONTROL OUTCOME VARIABLES 
BP < 140/90 mmHg for 2 years   
(a) Sociodemographic 
(b) Lifestyle 
(c) Secondary HTN 
(d) Comorbidity 
(e) Mental health 
(f) Medication 
























Figure 2.  Hypertension (HTN) Control Conceptual Framework (5th-domaine) 
Purpose Statement 
The purpose of this study was to describe multidimensional factors impacting 
veterans’ HTN control.  In this descriptive, exploratory, cross-sectional, retrospective, 
(g) Uncontrol HTN variable: 
SBP ≥ 140 mmHg 
Baseline ↔ Final 
(a) Socio-demographic 
variable 
(b) Lifestyle  
variable  








Branch of service 










Controlled HTN (DV):  
SBP < 140 mmHg 
Baseline ↔ Final 
 
(c) Secondary HTN 
variable OSA/Steroid  



















convenient sampling of primary data, 331 EMRs in a VA dashboard data set were 
reviewed for men and women veterans aged 24 and older with essential HTN in one 
Southern California VA primary care clinic from October 17, 2014 through October 17, 
2016.  Data was analyzed utilizing univariate, bivariate, and multivariate statistics. 
Research Aims and Questions  
Aim # 1.   
Describe the characteristics of hypertensive veterans in one Southern California 
VA clinic from data collected during a period of October 17, 2014 through October 17, 
2016. 
Question # 1.  
What were characteristics of hypertensive veterans in one Southern California VA 
clinic for the seven dimensions of IVs from data collected during a period of October 17, 
2014 through October 17, 2016? 
Aim # 2.   
Examine the relationships among the predictor variables of blood glucose level 
(A1C), high-density lipoprotein (HDL), body mass index (BMI), total number of BP 
medications prescribed, total number of clinic visits, baseline SBP and the outcome 
variable of the final point SBP. 
Question # 2a.  
Which of the possible six predictor variables were included in an equation for 





Question # 2b.   
Does the obtained regression equation resulting from a subset of the six predictor 
variables allow us to reliably predict veterans’ final point SBP?   
Aim # 3.   
Describe any significant association between and among non-normally distributed 
IVs and the final SBP. 
Question # 3.   
Can status of veterans’ final SBP be correctly predicted from knowledge of A1C, 
HDL, BMI, Baseline SBP?   
Aim # 4.   
Describe any relationships between categorical predictor variables (Yes/No) and 
an outcome variable of final controlled (SBP < 140) or uncontrolled (SBP ≥140).  
Question # 4.   
What were the significant relationships between age (≥60/<60), race (Black/non-
Black), religion (yes/no), tobacco use (yes/no), alcohol use (yes/no), OSA (yes/no), DM 
(yes/no), dyslipidemia (yes/no), BMI (≥30/<30), MDD (yes/no), GAD (yes/no), PTSD 
(yes/no), medication adherence (yes/no), brain damage (yes/no), heart damage (yes/no), 









Chapter 2: Review of the Relevant Literature 
The purpose of this chapter is to conduct a comprehensive review of the research 
literature relevant to key concepts of HTN control.  The chapter begins with a critical 
review of a JNC-7 guided study, an historic overview of JNC BP treatment goals, and 
HTN prevalence and risk factors.  Ultimately, a systematic review of the most up-to-date 
research studies is presented in domains of HTN prevention, detection, evaluation, 
treatment, and control outcomes.  The chapter will conclude with a summary of major 
themes based on the literature reviewed and will suggest how this study might further add 
to the scholarly nursing literature.   
JNC-7 as a Study Conceptual Framework 
A search of the literature using the key terms conceptual framework and JNC-7 
and hypertension and veteran was conducted in Academia Premier, CINAHL, Health 
Source (Nursing/Academic Edition), and PsychInfo within the past 5 years to identify 
peer-reviewed journal articles pertaining to articles that utilizes the JNC-7 as a conceptual 
framework.  This approach yielded 16 articles with non-veteran populations.  After 
screening the abstracts, only one article was found to be relevant to the focus of this study 
and was reviewed with attention to its study design. 
Koti and colleagues (2015) conducted a retrospective chart review to compare the 
documented provision of HTN care against JNC-7 HTN treatment guidelines (Chobanian 
et al., 2003).  In this study, the JNC-7 was utilized to develop a 15-item instrument used 
for EMR chart audits (Koti & Roetzbeim, 2015).  The provision of HTN care was scored 





1. Cardiovascular risk factor 
2. Identification of BP goal 
3. Communicating BP goal to patients verbally or in writing 
4. Monotherapy for Stage I HTN 
5. Combination therapy for Stage II HTN or Stage I HTN with comorbidity 
6. Notation of uncontrolled HTN by healthcare providers (BP ≥140/90 mmHg) 
7. Discussing lifestyle modification for ≥ 50% of encounter by providers 
Within the past 12 months: 
8. Fasting lipid panel 
9. DM, CKD, albuminuria 
10. Serum creatinine 
11. Blood glucose 
12. Hematocrit 
13. Serum potassium 
14. Serum calcium 
15. Electrocardiogram (EKG) measured at any point in the past  
The study sample of 150 cases included 83 women and 67 men (Mage = 64.7 
years; SD = 12.7 years) and clinic visits (M = 4.5; SD = 2).  The study reported HTN-
detection rate (96.7%), drug treatment rate (97.7%), healthcare provider’s explicit 
identification of BP goals (18.7%), communicating BP goal to patients (10.7%), 
discussion about lifestyle modifications at > 50% of their visits (22.0%), and HTN-





glucose, and potassium.  The study also found that married patients received more 
guideline-recommended care than unmarried patients (80.4% vs 74.4%, p <0.05) and 
men received more guideline-recommended care than did women (80.7% vs 76.4%, p 
<0.05%).   
Strengths of the study.   
The study design was conceptualized by JNC-7 and capable of addressing four 
domains of HTN control issues.  Koti and Roetzbeim (2015) provided innovation as 
evidenced by the creation of JNC-7 blueprint instrument for systematic chart auditing.  
The study incorporated clearly-defined inclusion and exclusion criteria.  The broad age 
spectrum of the study subjects (Mage = 64.7 years, SD = 12.7 years) was representative of 
hypertensive populations.   
Weaknesses of the study.   
The developed scoring instrument was not psychometrically validated prior to its 
application.  Additionally, the instrument scores were altered multiple times creating a 
threat to the instrument’s internal validity (Waltz, Strickland, & Lenz, 2010).  The 
practice of oversampling non-Hispanic Black and Hispanic patients to maximize 
statistical power for the study created a risk for selection bias, another threat to internal 






Knowledge gaps.   
JNC guidelines are not mandatory for providers; few studies have utilized JNC as 
a conceptual framework.  Healthcare providers must exercise their own clinical 
judgement when referring to this guideline (Chobanian et al., 2003). 
Historic Overview of Joint National Committee (JNC) BP Treatment Goals 
Understanding the rational of recent changes in BP treatment goals necessitated 
an historical perspective.  Studies by Ogihara et al. (2010) and the JATOS Study Group 
(2008) cited by JNC-8 (James et al., 2013), supporting these changes.  In 2014, the BP 
treatment goal for the general population was changed for people age 60 years or older (< 
150/90 mmHg; James et al., 2013), up from the previous goal (140/90 mmHg) found in 
the guidelines of JNC-4 through JNC-7 (Chobanian et al., 2003; "JNC 4," 1988; Pogue, 
Ellis, Michel, & Francis, 1996; Sheps, 1997).  Although the increase in this threshold was 
recommended based on Grade A, strong scientific evidence by JNC-8 (James et al., 
2013), it has not been without controversy among experts in the field.  First, the use of a 
various BP treatment goals has resulted in a variation of reported HTN prevalence and 
control, even when evaluating the same dataset (Crim et al., 2012).  Second, the increase 
in the threshold for this new BP goal precluded previously-eligible hypertensive patients 
from being eligible for care, potentially leading to negative health outcomes.  Third, JNC 
1 through JNC-7 guidelines were traditionally produced by the National Heart, Lung, and 
Blood Institute every 4 to 6 years, but JNC-8 was authored by the American Medical 
Association, whose guideline quality might be different (James et al., 2013).  Therefore, 





behind this change in BP treatment goal.  A title search in the Google Scholar database 
aided in locating two original research articles cited by JNC-8.   
Should SBP be decreased in hypertensive elders?   
Oibara and colleagues (2010) conducted a prospective randomized clinical trial 
(RCT) comparing the incidence of cardiovascular events between two groups of Japanese 
patients.  The strict group had a target SBP goal of less than 140 mmHg, while the 
moderate group had a target SBP goal between 140 mmHg and 150 mmHg.  The study 
sample comprised outpatients, ages 70 to 85, either gender, with seated SBP at or above 
160mmHg and DBP less than 90 mmHg at two-visits within 2 to 4 weeks, and on 
antihypertensive drug therapy that could be converted to valsartan.  Excluded from the 
study were patients with secondary HTN, malignant HTN, seated SBP at or greater than 
200 mmHg or DBP at or greater than 90 mmHg, history of CVA, MI in past 6-months, 
planned or previous arterio-plastic surgery within 6 months of study, Stage-3 CHF or per 
New York Heart Association (NYHA) criteria, severe aortic stenosis or valve disease, 
atrial fibrillation (a-fib), atrial flutter, arrhythmia, renal dysfunction with serum creatinine 
at or greater than 2 mg/dl, severe liver dysfunction, hypersensitivity to valsartan, or 
subjects deemed inappropriate for study per the investigators’ discretion (Ogihara et al., 
2004).  Utilizing a log-rank test, Kaplan-Meier, and Cox proportional hazard statistical 
analysis model, this study found that rates of adverse events were 18.2% in strict group 
vs. 17.9% in moderate group (p = .851), concluding that strict BP control with SBP 
greater than 140 mmHg might not be associated to the prevention of cardiovascular 





Strengths of the study.   
This study addressed a clinically significant question (Figure 1). The study profile 
was helpful with understanding participants’ flow.  Sample size calculations were 
present. Valsartan intervention, as well as primary and secondary end-point measures 
were described sufficiently. 
Weaknesses of the study.   
The age of the research subjects (M = 76.1, SD = 4.1) was too homogenous 
reducing its external validity, thereby making the results non-generalizable to populations 
younger than 72 years of age.  The major confounders of BMI and alcohol use were not 
statistically controlled.  Using this evidence as a rational to increase the threshold of the 
SBP treatment goal for people over 50 years of age was not scientifically sound because 
the study did not cover groups aged 50 years - 72 years, major confounders were not 
considered and controlled for, and major differences exist between Japanese and 
American cultures. 
Knowledge gap.   
An optimal SBP goal for people over age 50 remained unknown.   
Assessing the optimal SBP treatment goal.   
The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly 
Hypertensive Patients (JATOS) Study Group conducted a RCT to assess optimal SBP in 
Japan (JATOS Study Group, 2008).  The study had two intervention groups with a target 
treatment goal of SBP less than 140 mmHg in the strict treatment group and SBP at 140 





comprised of Japanese patients with essential HTN had a total of 2,212 subjects in strict 
treatment group (40% men, 60% women) and 2,206 in mild treatment group (38% men, 
62% women).  Subjects were aged 65 to 85 years with persistent SBP at or above 160 
mmHg, received either no drugs or the same drugs for 4 weeks, and efonidipine could 
either be given additionally or substituted for one of the drugs received before study 
entry.  Exclusion criteria were participants with DBP at or greater than 120 mmHg, 
secondary HTN, stroke, MI, angioplasty within past 6-month, angina requiring 
hospitalization, CHF at or greater than Class 2 per NYHA, a-fib, dissecting aneurysm of 
the aorta, occlusive arterial disease, hypertensive retinopathy, liver enzymes more than 
double the respective upper limits, fasting blood sugar at or greater than 200 mg/dl or 
A1C at or greater than 8 mg/dl, serum creatinine at or greater than 1.5 mg/dl, malignancy 
or collagen disease, and those deemed unsuitable for study (JATOS Study Group, 2008).   
The study found (a) the primary endpoint events (e.g., brain, heart, kidney) 
occurred among 86 patients in both treatment groups; (b) the secondary endpoint events 
(e.g., discontinuation of treatment due to adverse events) indicated that 54 patients died in 
the strict-treatment group, compared with 42 patients in the mild treatment group; and (c) 
rates of morbidity and mortality from the primary end-point and its components did not 
differ significantly between the two treatment groups.  Therefore, the study concluded 
that there was no significant difference in outcomes between the strict treatment group 





Strengths of the study.   
This study addressed a clinically significant question. As shown in Figure 1, the 
flowchart depicting the allocation of subjects was well-defined.  Sample size calculations 
were present and clear.  The efonidipine intervention as well as the primary and 
secondary end-point measures were described sufficiently. 
Weaknesses of the study.   
The study was fundamentally flawed for the following reasons:  
1. While the study has a strict and mild treatment groups, the RCT lacked a true 
control arm, one without any drug intervention; therefore, an objective 
comparison of the primary and secondary end events could not be.  Comparisons 
between the two intervention groups were made relative to each other by 
manipulating the interventional efonidipine or additional drugs and the baseline 
medication used in each group was not equivalent. 
The RCT design lacked detailed description about (a) the randomization 
allocation sequence (RAS) method in how RAS was generated, what mechanisms were 
used to implement RAS, and the party generating the RAS; (b) the person(s) enrolling 
participants; (c) the person(s) assigning participants to the intervention groups, (d) single 
blinded as only investigators were blinded and no detail about how they were blinded, 
what they were told about the study; (e) the exclusion criterion, “patients considered 
unsuitable as subjects were also excluded” (JATOS Study Group, 2008, p. 2117) 





2. There was absence of information about inter-rater reliability among all end-point 
evaluators.   
3. The sample characteristics did not include a mean and standard deviation for age 
in the strict and mild treatment groups.   
4. BMI for strict treatment group (M = 23.6, SD = 3.4) and mild treatment group (M 
= 23.6, SD = 3.5) were non-generalizable to the population of the United States 
where most M ±SD ≥ 30 ±4 is common based on 50 relevant articles reviewed. 
5. Table 3 was missing evidence of significant p-values, making the results invalid.   
In summary, this study had multiple internal and external validity concerns that 
suggest the results might be untrustworthy.  Changing national HTN-management 
guidelines without strong evidence or rationale could present a disservice to the medical 
and research community, potentially misleading stakeholders in the HTN-management 
process. 
Knowledge gap.   
Optimal SBP as well as primary and secondary end-point events described by the 
study could also be assessed through a systematic review of RCTs, nonrandomized trials, 
and/or meta-analysis of studies on patient populations within the United States.   
HTN Prevalence Rates and Risk Factors 
HTN is known as a disease of industrial society; its prevalence is low among 
hunters, herders, and traditional agricultural communities (Landsbergis, Dobson, 
Koutsouras, & Schnall, 2013).  Prevalence rates for HTN are essential in measuring the 





HTN among the world’s adults aged 21-year or older (31.1%; 95% CI [30.0%, 32.2%]), 
with high-income countries (28.5%; 95% CI [27.3%, 29.7%]) compared to low-or-middle 
income countries (31.5%; 95% CI [30.2%, 32.9%]; Mills et al., 2016).  From 2011 to 
2014, an overall prevalence of HTN among United States adults aged 18-year or older 
was 29.0%, was similar among men (30.0%) and women (28.1%), increased with age 
(7.3% for 18-39-year-olds, 32.2% for 40-59-year-olds, 64.9% for 60 years or older), and 
the controlled HTN rate was only 53% among adults aged 18-39 (Yoon, Fryar, & Carroll, 
2015).  From 2009 to 2012, an age-adjusted HTN prevalence among U.S. veteran men 
was 34.4% (95% CI [29.9%, 39.2%]); 2.2% higher than civilian population (Fryar, 
Herrick, Afoul, & Ogden, 2016).  In fiscal year 2010, HTN prevalence among U.S. 
veteran women aged 35-44-year-olds was 13%, 45-54-year-olds was 28%, and 55-64-
year-olds was 42% (Vimalananda et al., 2013).  A systematic review and meta-analysis 
found the prevalence of HTN among homeless adults in America was like the general 
population (Bernstein, Meurer, Plumb, & Jackson, 2015).  
A comparison of male veterans to male non-veterans in the United States from 
2009 to 2012 revealed that the prevalence of obesity was higher among male veterans 
(43% vs. 34%), yet similar in dyslipidemia (49%, 48%), diabetes (10% vs. 9%) and 
smoking (33% vs. 30%; Fryar et al., 2016).  In one study of almost 2 million veterans 
aged 65 years or older, risk factors for CV multimorbidities of HTN, CAD, and 
dyslipidemia were higher in men (37.4% vs. 22.0%); also reported were the prevalence of 
HTN (85% men, 82% women), dyslipidemia (78% men, 72% women), and CAD (46% 





A study by Fletcher et al. (2012) reported HTN control rates for veterans had 
improved 3% per year, to 76.3% over the 10-year period from 2000 to 2010.  However, 
this study had major systematic biases.  First, the definition of HTN (BP > 140/90 mmHg 
vs. BP ≥ 140/90 mmHg) was biased toward a higher HTN control rate based on JNC-7 
guideline (Chobanian et al., 2003).  Second, the definition of hypertensive as 3 or more 
days of elevated BP, rather than 2 or more days or 2 occasions, was biased toward a 
higher HTN control rate based on JNC-7 guideline.  Third, the exclusion criterion of 
missing readings without reporting the percent of missing data was a potential risk for 
bias toward a higher HTN control rate.  These risks for bias could have resulted in an 
inflated HTN control rate (76%) and was likely spurious considering the sample size 
included 582,881 veterans with HTN and 260,924 without HTN.  Therefore, the study 
conclusion was invalid. 
HTN Prevention Domain 
A search of the literature using key terms hypertension, prevention, qualitative, 
observational, longitudinal, cohort, quantitative, RCT, interventional, systematic review, 
meta-analysis and veteran in the databases of Academia Premier, CINAHL plus with text, 
Health Source: Nursing/ Academic Edition, Military, Google Scholar, and PsychInfo 
within past 5 years was performed to identify peer-reviewed journal articles pertaining to 
the HTN prevention domains within the framework.  The search yielded 47 articles.  
After reading through the abstracts, only two articles were relevant to the focus of this 





reference list in the selected articles.  The addition was older than 5 years, but deemed 
relevant and are therefore included in this review.   
HTN prevention strategy.   
Schmid and colleagues (2009) conducted a qualitative study to extract themes of 
the HTN prevention strategy among 28 hypertensive veterans with a history of stroke or 
transient ischemic attack.  Utilizing a mixed method design and a focus group interview 
approach, this study identified themes of external support, medication adherence, routine 
development, BP monitoring, and HTN risk factor management (e.g., heart healthy diet, 
exercise, stress reduction), and take advantage of teachable moments.   
Strength of the study.   
(a) The study addressed an important issue with HTN prevention.  (b) 
Interviewing bias was decreased by utilizing three independent stroke researchers apart 
from the moderator to review and transcribe interview data. This also increased the 
validity of the study result. 
Weakness of the study.   
Risk for self-selection sampling bias might have existed. The small sample size 
within one region might be a risk to external validity of the study results.   
Knowledge gap.   
Despite protentional methodological weaknesses, the results were consistent with 





Barriers of adherence to antihypertensive drug therapy.   
AlGhurair and colleagues (2012) reviewed 74 articles of patient’s self-reported 
barriers to the adherence of antihypertensive medications based on survey instruments 
with attention to their psychometric properties.  Adherence was defined as “the extent to 
which a person’s behavior correspond with agreed recommendations from a healthcare 
provider” (Sabate, 2003, p. 3).  The review found that most surveys addressed patient-
related adherence (76%). Other barriers included therapy (29%), healthcare system or 
team (27%), socioeconomic (22%), and condition-related (8%) The review stated that the 
Moriskey Medication Adherence scale (Morisky, Ang, Kardrousel-Wood, & Ward, 2008) 
was the most commonly used instrument (69% of survey studies), but only 20 out of 70 
(39%) had established reliability and validity evidence. 
Strengths of the study.   
(a) The review addressed self-reported barriers of adherence to antihypertensive 
medication issue.  (b) Both observational and experimental studies were included in the 
study design.  (c) Five major bibliographic databases were used to identify relevant 
studies to be reviewed, likely encompassing all important studies.  (d) Inclusion and 
exclusion criteria were stated clearly.  (e) The World Health Organization 
Multidimensional Adherence Model was utilized to guide the study.  (f) The tables were 
clear and well organized.  (g) The conclusions offered direction for future research. 
Weakness of the study.   
Adherence lacks a theory-based operational definition and linkage to healthcare 





Knowledge gap.   
Future research should examine multidimensional adherence models to guide the 
measurement of barriers to adherence of HTN treatment to help stakeholders appreciate 
how to optimize treatments and reduce the burden of uncontrolled HTN.  Most studies 
were poor in quality as only 39% out of 20 surveyed had evidence of validity testing 
(AlGhurair, Hughes, Simpson, & Guirguis, 2012). 
Self-measured BP monitoring and BP control.   
Uhlig and colleagues (2013) conducted a systematic review and meta-analysis to 
summarize evidence of the effectiveness of self-measured BP monitoring (SMBP) in 
adults with HTN.  The review included 52 prospective comparative SMBP studies versus 
usual care or an alternative SMBP intervention in persons with HTN and found that 
SMBP, with or without additional support, lowered BP compared with usual care, but the 
BP lowering benefits beyond 1 year was uncertain (Uhlig, Patel, Lp, Kitsios, & Balk, 
2013).  
Strengths of the study.   
(a) The review addressed a clearly focused issue on the effectiveness of SMBP.  
(b) Inclusion and exclusion criterion were clearly stated.  (c) The databases searched were 
broad enough to have included all important, relevant articles.  (d) All articles included in 
the review were evaluated for quality.  (e) The numerical BP results were reported 





Weaknesses of the study.   
Although JNC-7 recommended SMBP with validated BP devices, this practice 
has not been popular for two reasons.  First, most hypertensive individuals did not need 
SMBP, except for patients with white coat syndrome, persistent HTN, or orthostatic 
hypotension.  Second, the accuracy of SMBP could not be guaranteed as most healthcare 
providers were reluctant to document the results of SMBP as a part of the patient’s 
medical record).   
Knowledge gap.   
The validity of SMBP has been uncertain and should be used only if clinically 
indicated and at the clinician’s discretion.   
HTN Detection Domain 
A search of the literature using the key terms hypertension, detection, qualitative, 
quantitative, RCT, cohort, systematic review, meta-analysis, secondary HTN, drug 
induced, primary aldosteronism, renal artery stenosis, pheochromocytoma, coarctation of 
aorta, thyroid and parathyroid disease in the databases of Academia Premier, CINAHL 
plus with text, Health Source: Nursing/Academic Edition, Military, and PsychInfo within 
the past 5 years was performed to identify peer-reviewed journal articles pertaining to the 
HTN detection domain within the framework.  The search yielded 138 articles.  After 
reading through the abstracts, only one article was relevant to the focus of this study.  The 
article was older than 5 years with smart-text search, but was deemed relevant and 






Handler (2003) provided an in-depth discussion on secondary HTN specific to 
drug-induced HTN through a case study methodology.  The case began with a history of 
present illness (HPI); the patient was a 59-year-old female who presented in a HTN clinic 
for persistent HTN (e.g., BP 180-200/80-110 mmHg between home and clinic for 6 
months) in December 2001.  Her past medical history (PMH) included 12 years of 
controlled HTN on HCTZ monotherapy, clonidine, and/or Felodipine for 6 months with 
no effect and Tylenol® for osteoarthritic knee pain.  Her brother, a physician, prescribed 
Celebrex® 200 mg QD for her knee pain; she also reported taking various herbal 
medicines to enhance well-being.  On physical exam (PE), she was an overweight female 
with BP 182/94 mmHg, HR 100 beats/min., heart and lungs sound normal, and 1-2+ 
ankle edema were noted.  Laboratory included a urine analysis negative for proteinuria 
and a serum creatinine that was 1.2 mg/dl.  The extent of polypharmacy was not 
appreciated until she was asked to bring in her pill bottles, including all prescription and 
over-the-counter medications.  That is when it was discovered that she was taking 
Celebrex® and an herbal supplement containing ginger root.  Once she stopped taking 
the Celebrex, her BP dropped to 138/86 at the 3-week follow-up appointment.  Removal 
of Felodipine led to a resolution of her ankle edema and palpitation.  Clonidine was 
tapered off subsequently.  
Upon analysis, Handler (2003) linked two results from a meta-analysis that 
explored the association between nonsteroidal anti-inflammatory drugs (NSAIDs) and 





NSAID-induced BP increased from “6.10 mm for Naproxen, 4.77 mm for Indomethacin, 
2.86 for Piroxicam compared to 2.20 for Sulindac and -0.30 mm for Ibuprofen” (Pope, 
Anderson, & Felson, 1993, p. 83).  Another study reported an NSAID-induced BP 
increase of 6.2 mm and that Sulindac affected BP the least amount (Johnson, Nguyen, & 
Day, 1994).  A greater risk for increased BP existed when patients took both NSAIDs and 
prescribed β-blocker concomitantly (Handler, 2003).  Mechanism of NSAID induced 
HTN was associated with an “inhibition of synthesis of vasodilatory and natriuretic 
prostaglandins” (p. 83).  Ginger root was thought to have some anti-inflammatory effect.  
The study concluded that high BP might occur with discontinuation of clonidine and/or 
methyldopa.  In addition, surveying patients about their store-bought supplements was 
essential to ensure that patients were not inadvertently causing any secondary HTN. 
Strengths of the study.   
The study design was appropriate for addressing the NSAID-induced HTN issue.  
In both studies, the setting and subjects were representative of hypertensive veterans.  
The researcher clearly articulated his perspective, which was backed up by the data 
collection methodology (e.g., PHI, PMH, PE).  The method of data analysis was valid 
when referring to findings from two previous meta-analyses.  The result was relevant to 
patients and providers in healthcare settings and was transferable. 
Weaknesses of the study.   
The study lacked a clearly stated research question (e.g., Could Celebrex and 





Knowledge gap.   
Many drugs were listed as potential for drug induced HTN, only a few have 
established case studies in the literature.  More case studies are needed to establish solid 
scientific background for other drugs listed in the literature.  
HTN Evaluation Domain 
A search of the literature using key terms hypertension, evaluation, qualitative, 
observational, longitudinal, cohort, quantitative, RCT, interventional, systematic review, 
meta-analysis and veteran in the databases of Academia Premier, CINAHL plus with text, 
Health Source: Nursing/ Academic Edition, Military, Google Scholar, and PsychInfo 
within past 5 years was performed to identify peer-reviewed journal articles pertaining to 
the HTN evaluation domains within the framework.  The search yielded 38 articles.  
After reading through the abstracts, only a handful articles were relevant to the focus of 
this study and they were selected for review.  Additional articles were found from the 
reference list in the selected articles.  These additions were older than 5 years, but 
deemed relevant and are therefore included in this review.   
Longitudinal predictors of masked HTN.   
Skårn and colleagues (2015) conducted a longitudinal study with 10-20 years’ 
follow-up to identify longitudinal predictors of masked HTN defined as normal clinic BP 
and hypertensive out-of-office.  The study was relevant because masked HTN could not 
be revealed by routine office BP measurements but could still be associated with CVD 
events.  HTN was defined as an average office BP at or above 140/90 mmHg; ambulatory 





night (22:00-06:00 hour) SBP/DBP at or above 120/70 mmHg; white-coat HTN was 
defined as BP at or above 140/90 mmHg in the office but normal out-of-office; sustained 
HTN was defined as BP at or above 140 mmHg both in the office and out-of-office 
settings.  The study design included 100 Scandinavian men (Mage = 22, SD = 1), healthy, 
and not on any medications.  Subjects were recruited while attending compulsory medical 
screening at a military draft laboratory in Norway from 1991 to 2002; these readings 
served as the baseline.  From January 2012 through November 2013, 17 years later, 
follow-up measurements were taken on subjects (Mage = 39, SD = 4).  Predictor variables 
included age, fasting blood sugar (FBS), total cholesterol, triglycerides, BMI, waist 
circumference (WC), daily smokers, office SBP/DBP, ambulatory SBP/DBP, white coat 
BP, persistent BP, HR, adrenaline at rest and during activity; data were collected by two 
people at baseline.  A physician performed follow-up data collection.  The study found 
that participants with high screening BP at baseline had a much higher likelihood of 
having masked HTN at follow-up (40%) compared to men with low screening BP (OR = 
4.8, 95% CI [1.7, 13.5], p < .05). 
Strengths of the study.   
(a) The abstract provided a concise summary of the main features of the report.  
(b) The introduction provided the rationale and aims for the study.  (c) All tables and 
figures were clear, simple, and independent.  (d) Key study variables were clearly 
operationally defined.  (e) An effort of more than 17 years for this longitudinal study has 





Weaknesses of the study.   
The cross-sectional study result was not transferable to patients in the United 
States for several reasons.  (a) Operational definitions of ambulatory and masked HTN 
were inconsistent with JNC-7 HTN management guideline.  (b) The study design lacked 
a detailed description of follow-up method, the study mentioned that subjects were not on 
any medications at baseline, yet omitted participants’ medication status at follow-up, and 
the inter-rater reliability statistic was not addressed; however, two people were involved 
in the data collection process at baseline posing threats to internal and external validity.  
(c) There was only one follow-up measurement point in the rare longitudinal study; 
results could have been different with two or more measurements.  (d) There was no 
power analysis for the statistical analyses used by the study.  (e) Reliability and validity 
of the Smart Diet instrument in the original study and within the study sample were 
omitted, another threat to internal validity and ultimately could affect external validity.  
(f) There was no table or description of how the researchers controlled for major 
confounders (e.g., alcohol consumption, physical activity, diet, weight, BMI, medication) 
at baseline and at the final point of data collection.  Nevertheless, one could view the 
introduction of masked BP as either a new challenge within the complex HTN control 
research arena or an unremarkable phenomenon considering that HTN research has yet to 
identify an optimal SBP for individuals with HTN.   
Knowledge gap.   
The associations between adolescent and adult BP in longitudinal studies is 





Deep breathing: A test of the white coat effect.   
Tomičić and colleagues (2015) conducted a controlled clinical trial to evaluate the 
reliability of a deep breathing test to detect the white coat HTN phenomenon.  The study 
sample consisted of hypertensive men and women who were age and gender stratified; 
106 subjects from 53-72 years old in the intervention group and 108 subjects from 59-72 
years old in the control group.  Data were collected during outpatient visits.  The control 
group had standard BP measurements and the intervention group had BP readings done 
after 30 seconds of slow, deep breathing for three or four cycles.  Utilizing a receiver 
operating characteristic (ROC) curve methodology, the study found slow, deep breathing 
of 30 seconds for three or four cycles (DBT) was the best detection for white coat HTN.  
DBT was associated with a 15% or more reduction in SBP with a sensitivity of 94% 
(95% CI [72, 100]).  A BP reduction of 8% or less could rule out white coat HTN with a 
specificity 78.4% (95% CI [64%, 85.9%]).   
Strengths of the study.  
(a) The abstract precisely captured the features of the main study.  (b) The study 
design was helpful in advancing science on the topic. 
Weaknesses of the study.   
(a) The conclusions drawn were misleading as 78.4% specificity of the deep 
breathing test does not meet a reliability standard of 90% for a clinical test (Rice, 2013). 
(b) Deep breathing may cause hyperventilation-associated numbness and tingling, 





Knowledge gap.   
More innovative studies are needed to find a reliable clinical test to help 
differentiate white coat HTN from resistant HTN in primary care settings.   
Diagnosis and treatment of resistant HTN.   
Waeber and colleagues (2014) published an article to discuss the issue of 
diagnosing and treating resistant HTN.  The authors cited multiple studies in forming 
their conclusion that a systematic out of office BP recording by either 24-hour 
ambulatory BP monitoring or self-measurement at home were necessary to properly 
diagnose patient with resistant HTN (Waeber et al., 2014).  For treating resistant HTN, 
these authors recommended a triple-drug regimen to include diuretic, blocker of the 
renin-angiotensin system, and calcium channel blocker to not only normalize BP, but to 
regress target organ damage and delay cardiorenal complications.  Several definitions of 
terminology made by the author group were useful for HTN research.  For example, 
uncontrolled and resistant HTN were similar in the definition of BP (≥140/90 mmHg), 
but differed by the number of antihypertensive drugs patients took to lower their BP.  In 
uncontrolled HTN, patients’ BP remained above 140/90 mmHg regardless of the type and 
the number of antihypertensive agents taken, whereas in resistant HTN, patients’ BP 
remained above 140/90 mmHg regardless of lifestyle measures and the concurrent use of 
three antihypertensive agents belonging to different classes with all drugs being 
prescribed at full dosage, including one diuretic (Waeber et al., 2014).  Patients with 
white coat HTN were resistant to antihypertensive treatment (BP ≥ 140/90 mmHg) in the 





Strengths of the study.  
The authors, consisted experts in the field, provided a candid discussion from 
their review of the empirical literature.   
Weaknesses of the study.  
(a) This article was based on a literature review of original publications rather 
than being an empirical study.  (b) The definition of uncontrolled HTN could overlap 
with the definition of resistant HTN; the number of antihypertensive drugs defined were 
vague.  (c) The concepts of uncontrolled HTN, resistant HTN, and white coat HTN were 
similar in the context of HTN treatment and should be further developed.  (d) The 
measurement of 24-hour ambulatory BP is labor intensive and home BP monitoring is 
potentially unreliable associated with calibration and or BP taking technique variabilities 
and cheating, raising validity concerns.    
Knowledge gap.   
More studies are needed to evaluate any overlap in defining the concepts of 
uncontrolled HTN, resistant HTN, and white coat HTN.  In addition, more studies are 
needed to evaluate a sufficient way to diagnose and treat resistant HTN utilizing a 
behavior modification approach.   
Orthostatic hypotension and orthostatic HTN.   
Wecht and colleagues (2016) conducted a cross-sectional survey to investigate 
rates of prevalence in orthostatic hypotension (OH) and orthostatic hypertension (OHTN) 
and associated factors among U.S. veterans.  A convenient sample of 286 veterans was 





unable to stand for 10 consecutive minutes, had an illness, infection, or were pregnant at 
the time of recruitment.  Outcome measures included heart rate and BP, collected with an 
automated sphygmomanometer BP cuff, and orthostatic symptoms were collected by a 6-
item, 10-point orthostatic hypotension symptom assessment (OHSA) scale (Wecht et al., 
2016).  Utilizing univariate X2, ANOVA, binary logistic regression, and logit calculation 
data analysis, this study reported that: (a) 14% of veteran participants had OH, 22% had 
OHTN, and 64% had normal BP (control group); (b) an increased prevalence of OH and 
OHTN among veterans with DM (27%) and HTN (63%); (c) veterans with OH were 
older than the control group and were taking more antihypertensive drugs than the control 
and OHTN groups; (d) the prevalence of OH increased with age, the OHTN was 
comparable in young (20-30) and old (70+) veterans (17% vs. 19% respectively), the 
severity of fatigue and dizziness increased in veterans with OH and OHTN compared to 
the reference group. 
Strengths of the study.  
(a) The title captured the study phenomenon and population involved.  (b) The 
abstract provided a precise summary of the main features of the report.  (c) The 
introductory paragraph provided sufficient background information and rationale for 
conducting the study and the purpose statement was clear.  (d) Key study variables (e.g., 
OH, OHTN, orthostatic symptoms) were operationally defined.  (e) Findings were 





Weaknesses of the study.   
(a) The study design lacked detailed descriptions identifying who collected the 
data, the data collection period, the type of clinic, the number of interviewers, and the 
location of the interviews.  While minor, these research design issues could create risks 
for bias.  (b) The omission of reliability and validity data about the original OHSA scale 
with this type of study sample could pose a threat to internal and external validity.  (c) 
The article did not reveal the identity of the person(s) analyzing the data.  (d) a power 
analysis should have been included estimating the minimum required sample size.  The 
cross-sectional study results from a convenience sample (N = 286) without power 
analysis at a single site presented concerns with validity and credibility. 
Knowledge gap.   
Tests for the reliability and validity of an OHSA scale with the study sample 
could have been conducted with resulting indexes being reported; therefore, replicating 
the study could correct this methodological weakness.   
Patients’ evaluation of appropriateness of HTN management.   
Morecroft and colleagues (2006) conducted a semi-structured interview to 
evaluate the appropriateness of HTN management to extract attributes from patients’ 
perspectives.  The purposeful sample of 28 patients (12 women, 16 men), ages ranging 
from 20 to 78-year-olds (M = 59 years), with an average of 10 years of HTN treatment in 
East England were selected for the study.  Findings reported that all patients considered 
their HTN management regimen appropriate with two attributes justifying their decision: 





relationship with the General Practitioner [GP], lowering of the BP).  Implicit attributes 
were those not consciously known by patients, but inherently meaningful to them (e.g., 
anxiety with concern of treatment and diagnosis, explanation of consequences from HTN 
treatment, choice with number of antihypertensive drugs, side effects experienced from 
taking antihypertensive drugs).  The study suggested that having patients evaluate the 
appropriateness of their HTN treatment might be unsuitable as (a) patients might not be 
familiar with the concept of appropriateness in terms of their prescribed HTN treatment, 
(b) patients might not be knowledgeable of medical terminology, (c) patients might prefer 
to rely on their GP to interpret BP readings as okay, as before, higher/lower rather than 
taking personal responsibility.  
Strengths of the study.   
(a) The title suggested a phenomenon of patients’ evaluation of the 
appropriateness of their HTN management using qualitative methodology.  (b) The 
abstract provided a concise summary of the main features of the report.  (c) The 
introductory paragraph provided sufficient background information with the rationale for 
doing the study.  (d) The research aims and questions were explicitly stated.  (e) 
Inclusion/exclusion criteria were appropriate.  (f) The sample size was adequate for 
saturation of the themes.  (g) The data collection method and audiotaped interview time 
(45-60 minutes) in patients’ homes were adequate.  (h) The figures detailing the interview 
questions, mind-map, and example of a pen portrait were helpful for readers to quickly 





quantitative findings were validated by member checking and were trustworthy.  (j) The 
discussion was thoughtful and conclusions were thought provoking.   
Weaknesses of the study.   
The plethora of interview questions could be burdensome for some patients, but 
was not mentioned as a limitation.   
Knowledge gap.   
Additional similar studies should be conducted among VA patients and VA 
healthcare providers to gain these perspectives both qualitatively and quantitatively.   
Twenty-four-hour blood pressure variability.   
Pengo and colleagues (2015) conducted a 24-hour observational study to analyze 
the changes in 24-hour BP variability (BPV) in relation to determinants (e.g., age, sex, 
medication, absolute BP, nocturnal fall) among patients with controlled and uncontrolled 
BP.  The justification for this study was based on the association between BPV, CV 
events, and mortality without known determinants.  BPV was defined as the fluctuation 
of BP values among various measurements over a defined time that were influenced by 
behavioral, environmental, and humoral factors as well as neural central reflex stimuli.  
The study sample comprised 446 subjects (53% male, 47% female; Mage = 57, SD = 16), 
with essential HTN but without secondary HTN, who were recruited at an HTN clinic in 
Italy between December 2010 and March 2013.  Outcome measures were 24-hour 
ambulatory BP (AMBP), daytime SBP/DBP, night-time SBP/DBP, nocturnal fall, 
dippers, non-dipper, extreme dippers, and 24-hour activity diary including time of meals, 





multiple comparison test, and multiple linear regression, this study found (a) no 
significant mean differences in BPV between subgroups with controlled and uncontrolled 
BP; (b) 24-hour BPV significantly increased in patients with uncontrolled BP, especially 
at night; (c) the number of antihypertensive drugs used was not a predictor for BPV in 
patients with uncontrolled HTN; (d) more than 40% patients were incorrectly classified 
as resistant HTN rather than BPV.  The conclusion was that absolute BP, nocturnal BP 
falls, and age were predictive of one’s BPV. 
Strengths of the study.   
(a) The study examined a novel phenomenon associated with HTN control.  (b) 
Reporting was concise.  (c) Tables and figures were well organized and self-explanatory.  
(d) The discussion included a detailed explanation of the findings and associations with 
previous research studies.   
Weaknesses of the study.   
Study results were less credible for the following reasons.  (a) The study design 
lacked a detailed description in inclusion and exclusion criteria, data collection procedure 
identifying who measured the 24-hour ambulatory BP and counted items in the 24-hour 
diary, operational definitions of key study variables (e.g., controlled BP, uncontrolled BP, 
absolute BP, resistant BP), power analysis to support the sample size.  (b) The cross-
sectional study design with data collection in 24-hours, then analyzed retrospectively, 






Knowledge gap.   
This topic has been extensively studied for over 30 years.  A systematic review or 
meta-analysis investigating the association between BPV, CV events, and/or mortality 
should be done to evaluate the significance of topic.   
HTN Treatment Domain 
A search of the literature using key terms hypertension, treatment, qualitative, 
observational, longitudinal, cohort, quantitative, RCT, interventional, systematic review, 
meta-analysis and veteran in the databases of Academia Premier, CINAHL plus with text, 
Health Source: Nursing/ Academic Edition, Military, and PsychInfo within past 5 years 
was performed to identify peer-reviewed journal articles pertaining to the HTN treatment 
domains within the framework.  The search yielded more than 200 articles.  After reading 
through the abstracts, only a handful articles were relevant to the focus of this study and 
they were selected for review.  Additional articles were found from the reference list in 
the selected articles.  These additions were older than 5 years, but deemed relevant and 
are therefore included in this review.   
DASH diet and body weight.   
Soltani and colleagues (2016) conducted a systematic review and meta-analysis to 
assess the effects of a dietary approach to stop HTN (DASH) on body weight and 
composition among adults.  The 13 reviewed articles were captured from the databases of 
PubMed, EMBASE, Scopus, and Google Scholar through December 2015.  This study 





2.03, -0.82]), BMI by -0.42 kg/m2 (95% CI [-0.64, -0.20]) and waist circumference (WC) 
by -1.05 cm (95% CI [-1.61, -0.49]) over a period of 8 weeks to 1 year.   
Strengths of the study.   
(a) The study addressed a clearly focused issue.  (b) The search of four 
bibliographic databases and inclusion of 13 articles adequately included important, 
relevant articles assessing the effect of DASH on weight and body composition in adults.  
(c) The table presentation was helpful for reviewers to grasp the study sample 
characteristics quickly.  (d) There was no publication bias per Begg’s and Egger’s tests.  
(e) The results appeared to be in line with the JNC-7 guideline (Chobanian et al., 2003). 
Weaknesses of the study.   
Although the study reported a non-publication bias by funnel plotting, referring to 
a figure, that figure was missing from the report.   
Knowledge gap.   
The omission of a figure illustrating funnel plots for non-publication bias was a 
quality gap by the study.  Replication of this study is necessary to confirm the study 
result. 
Body weight and blood pressure.   
Neter and colleagues (2003) conducted a meta-analysis of RCTs to estimate the 
effect of weight reduction on BP.  A total of 25 RCTs published between 1966 and 2002 
were included in the meta-analysis.  This study found a net weight reduction of -5.1 kg 
(95% CI [-6.03, -4.25]) by means of energy restriction and physical activity, reduced SBP 





2.25]).  Significantly larger BP reduction were observed in populations with an average 
weight loss of more than 5 kg when compared to populations with less weight loss both 
for SBP (-6.63 mmHg, 95% CI [-8.43, -4.82] vs. -2.70 mmHg, 95% CI [-4.59, -0.81]) and 
DBP (-5.12 mmHg, 95% CI [-6.48, -3.75] vs. -2.01 mmHg, 95% CI [-3.47, -0.54]).  The 
study concluded that weight reduction was important for HTN prevention and treatment. 
Strengths of the study.   
(a) The study addressed a significant HTN prevention and control issue in a 
scientifically rigorous manner.  (b) The data sources were all RCTs; theoretically more 
reliable results when compared with non-RCTs. 
Weaknesses of the study.   
A risk of bias existed due to an extreme outlier indicated on the funnel plot of 
SBP (p. 879) and the results of meta-analysis might have concluded otherwise without 
the outlier article.   
Knowledge gap.   
(a) The relationship between weight reduction and BP, particularly beyond 1 year, 
remined unknown.  (b) HTN research needed evidence from longitudinal studies of the 
relationship between weight reduction and BP with three to five observational time 
intervals over 3 to 5 years of follow-up.  (c) The meta-analysis needed to pull data from 
longitudinal study greater than 2 years of weight reduction and BP change to be helpful 





Sedentary behavior and blood pressure.   
Lee and Wong (2015) conducted a systematic review and meta-analysis to 
examine the association between time spent in sedentary behaviors and BP.  The 31-
articles in the review were published from 2002 to 2014.  Out of the 31-articles, 21 of the 
studies (67.7%) used SBP and/or DBP as an outcome measure; those 21 studies reported 
an association between sedentary behaviors and SBP (n = 14; 66.7%) or DBP (n = 11; 
51.1%).  Sedentary behavior was defined by energy expenditure (≤ 1.5 metabolic 
equivalent task) while in a sitting or reclining posture.  The study found that an additional 
1 hour of time spent in sedentary behaviors per day was associated with an increase of 
0.06 mmHg of SBP (N = 108,228; 95% CI [0.01, 0.11]; p = .01) and 0.20 mmHg of DBP 
(N = 107,791; 95% CI [0.10, 0.29]; p < .001).  The study concluded that self-reported 
sedentary behavior was associated with BP elevation. 
Strengths of the study.   
(a) The title suggested the study phenomenon and identified the report as a 
systematic review and meta-analysis.  (b) The abstract provided a clear and precise 
summary of the features of the study.  (c) The introductory paragraph provided a clear 
aim and study hypothesis.  (4) There was no evidence of publication bias.   
Weaknesses of the study.   
A causal relationship of sedentary lifestyle on BP was not established. 
Knowledge gap.   
More longitudinal and RCT studies are needed to establish evidence of causal 





Effects of flaxseed consumption on blood pressure.   
Khalesi and colleagues (2015) conducted a systematic review and meta-analysis 
to assess the effects of flaxseed consumption on BP.  Eleven RCT and non-RCT articles 
were reviewed utilizing MEDLINE, CINAHL, and Cochrane Library Central published 
through July 2014.  This study found that flaxseed supplementation reduced SBP (-1.77 
mmHg; 95% CI [-3.45, -0.09]; p = .04) and DBP (-1.58 mmHg; 95% CI [-2.64, –0.52]; p 
= .003).  When consuming whole flaxseed, the DBP reduction was significantly greater (-
1.93 mmHg; 95% CI [-3.65, -0.21]; p < .05); for durations of 12 week or longer, the DBP 
reduction was even greater (-2.17 mmHg; 95% CI [-3.44, -.89]; p < .05).  Conclusions 
indicated that flaxseed consumption lowered BP slightly and the benefit was greater 
when consumed as whole seed for 12 weeks or more.   
Strengths of the study.   
(a) The study title identified the report as a systematic review and meta-analysis 
of controlled trials.  (b) The abstract provided a precise summary of the study.  (c) The 
introductory paragraph included background information, a rationale for the review, and 
study objectives.  (d) The methodology included the review registration number 
(CRD42014010248), eligibility criteria, inclusion/exclusion criteria, information sources, 
search strategies, process of study selection, data extraction, and quality assessment 
protocols.  (e) Key variables were operationally defined based on JNC-7.  (f) Figures and 
tables were clear and independent.  (g) Results were detailed showing each study’s 
sample characteristics.  (h) The risk for bias was low with Rosendal scores between 50% 





displayed in a forest plot.  (j) The review gave direction for future research.  (k) The 
review could serve as an exemplar of systematic review and meta-analysis. 
Weaknesses of the study.   
The duration of flaxseed consumption (3-48 weeks) was inadequate for evaluating 
its long-term benefit (> 1 year) for SBP/DBP reduction.   
Knowledge gap.   
(a) Potential side effects of flaxseed supplement should be studied among VA and 
non-VA populations.  (b) Qualitative study is needed to explore the mechanisms of how 
flaxseed influences changes in BP (Khalesi et al., 2015). 
Meaning of antihypertensive drug therapy.   
Hultgren and colleagues (2014) conducted a qualitative study examining the 
meaning of antihypertensive drug therapy among hypertensive patients at a primary care 
clinic in Western Sweden.  The study sample consisted of a purposive sample of 10 
subjects (N = 6 men, 39-68 years old, M = 50 years; n = 4 women, 51-66 years old, M = 
59 years) with various occupational backgrounds and on HTN treatment from 1 1/2 
months to 15 years.  This study revealed that patients’ experience with antihypertensive 
drug therapy was a process where attitudes and behaviors changed from resistance to 
medication (e.g., worry, side effects, lack of autonomy), to rescue medication (e.g., desire 
for life style changes), to normal medication (e.g., trust healthcare).   
Strengths of the study.   
(a) The articles revealed many words useful for instrument development (e.g., 





fear, knowledge, attitude, accept or resist, stroke, brain bleeding, heart infarction, worry, 
lack of autonomy or control, normal or perfect, confidence).  (b) Information on 
informants clarified the sample characteristics.  (c) The model presented clarified the 
themes developed by the study.   
Weaknesses of the study.   
(a) The description of the phenomenological study design did not include the time 
needed to complete the study.  (b) The claim of increased validity utilizing all three 
authors in the analysis of data could not be confirmed without evidence of intercoder 
agreement or cross-checking (Creswell, 2014).  (c) The discussion section included new 
ideas that would be more appropriate in the literature review.  (d) The qualitative 
generalizability of the study results may be limited to Swedish population rather than 
U.S. veterans (Creswell, 2014).  
Knowledge gap.    
No studies have explored the meaning of antihypertensive drug therapy from the 
perspective of U.S. veteran patients.  
Meaning of adherence to antihypertensive drug treatment.   
Lahdenperä and Kyngäs (2001) conducted a qualitative study to describe 
hypertensive patients’ treatment compliance and its deeper meaning in terms of 
“intention, activity, responsibility and collaboration” (p. 189).  The study included 21 
subjects, 9 males and 12 females (M = 46 years, range 32-63 years), who were diagnosed 
with HTN, on either antihypertensive medication or no medication for 1 year with a 





the information from a previous study, and interviewed at either a municipal health care 
center or a Department of Nursing Health Administration in Finland.  The study revealed 
four levels of compliance (i.e., subconscious, cognitive, action, attitudinal) and attitudes 
toward HTN treatment (i.e., careless, serious, adjusted well, frustrated).  The authors 
recommended that healthcare professionals listen to patients’ various levels of 
compliances and attitudes with regards to their HTN treatment.   
Strengths of the study.   
(a) The title suggested a phenomenon of compliance by hypertensive patients and 
their attitudes toward their illness.  (b) The abstract provided a concise summary of the 
main features of the report.  (c) The problem statement indicated that hypertensive 
patients often did not have any symptoms, did not feel ill, did not see any reason to treat 
themselves and provided the rationale to conduct this study.  (d) The key concept of 
compliance, defined as “patients work to maintain their health in accordance with health 
regimens and in collaboration with healthcare professionals” (Lahdenpera & Kyngas, 
2001, p. 190), emphasized that patients’ responsibility was consistent with the theory of 
self-care agency (Renpenning & Taylor, 2003).  (e) Inclusion and exclusion criteria were 
appropriate.  (f) Sample size seemed to be adequate to gain a saturation of themes; the 
setting was appropriate.  (g) The 45 to 60 minutes allowed for audiotaped interview was 
adequate.  (h) The patients’ definition of the nursing role was “not that of a partner in 
care, but that of a provider of nursing services congruent with the patient’s identified 
goals” (Lahdenpera & Kyngas, 2001, p. 193) was consistent with self-care deficit theory 





1971), the levels of compliance and attitudes toward HTN treatments were validated by 
the authors reviewing research materials multiple times and utilizing a two-phased 
categorization data analysis approach, making it trustworthy and potentially useful in the 
development of an adherence instrument in the future. 
Weaknesses of the study.   
Validity for the study could be further strengthened with triangulation.   
Knowledge gap.   
No qualitative study has elicited the meaning of adherence to antihypertensive 
drug therapy from patients and primary healthcare providers’ perspectives within the VA 
system; these studies would be important for instrument development in the future.   
Family nurse practitioners’ experience with pre-HTN care.   
Hernandez and Anderson (2012) conducted three-dimensional qualitative 
inquiries to explore family nurse practitioners’ (FNP) experience of caring for pre-HTN 
patients Interviewing eight FNPs, five males and three females with 4 months to 18 years 
of practicing experience in urban, rural, and suburban areas.  This study revealed that 
caring for pre-HTN patients was a complex and multifaceted experience and three major 
themes emerged: (a) FNPs often failed to address the pre-HTN condition due to a time 
constraints, patients had other urgent health problems that needed to be addressed at that 
visit, or lack of reimbursement for addressing pre-HTN due to insurance or lack of public 
support; (b) FNPs experienced frustration and bewilderment with their role identity due 
to a conflicting practice model (holistic vs. medical), FNPs practiced the medical model 





hope (e.g., ability to promote cardiovascular health by being a good listener, educator, 
follow the JNC-7 guidelines) for pre-HTN patients despite multiple barriers (e.g., sense 
of betrayal by patients who promised to follow lifestyle modifications, no-show for 
follow up appointments); this frustration could be avoided by not addressing pre-HTN 
issues with non-compliant patients.   
Strengths of the study.   
The result of the study was a powerful, well-written story.  (a) The methodology 
was appropriate for addressing the research goal.  (b) The purposive sampling method 
provided diverse FNP experts with rich narratives.  (c) Data collection was completed in 
30-90 minutes in a private, mutually-agreed upon location with semi-structured interview 
method; an appropriate framework.  (d) Results of this study were trustworthy; themes 
were consistent with findings of similar qualitative studies.  
Weaknesses of the study.   
It would be better if this was a mixed study design in that the magnitude of 
themes (e.g., patients’ refusal to discuss lifestyle modification, no show at HTN follow-
up clinic) may be addressed simultaneously.  HTN control research needs improved data 
collection for precision in targeting the problem. 
Knowledge gap.   
No qualitative study of HTN detection with sample of VA patients or VA 
healthcare providers could be found.  Evidence suggests a sufficient lack of quantitative 
study detecting associations between refusing lifestyle modifications and the magnitude 





HTN Control Domain 
A search of the literature was performed utilizing the databases of Academia 
Premier, CINAHL plus with text, Health Source: Nursing / Academic Edition, Google 
Scholar, and PsychInfo within past 5 years to identify peer-reviewed journal articles 
pertaining to the domain of HTN control.  Key terms included hypertension, control, 
blood pressure, systolic, diastolic, BP, age, sex, race, ethnicity, religion, religiosity, 
education, health literacy, disability, insurance, copay, socioeconomic, demographic, 
tobacco, smoking, alcohol, DASH, exercise, caffeine, coffee, stress, job strain, OSA, 
diabetes, A1C, dyslipidemia, HDL, obesity, BMI, depression, anxiety, PTSD, 
antihypertensive, medication adherence, clinic visit, end organ damage, stroke, transient 
ischemic attack, heart failure, coronary heart disease, myocardial infarction, CABG, 
CKD, and veteran.  This approach yielded from zero to over one hundred articles under 
each category per the HTN control conceptual framework.  After screening the abstracts, 
a few articles with high level of relevancy were selected for review.  Additional articles 
were found from the reference list in the selected articles.  These additions were older 
than 5 years, but deemed relevant and are therefore included in this review.   
Socio-demographic variables impacting HTN control. 
Age and blood pressure.   
Presently, no credible evidence could be found to suggest a statistically significant 





Sex and blood pressure.   
No credible evidence showing a statistically significant sex differences in SBP or 
DBP utilizing systematic review and/or meta-analysis.   
Racial discrimination and HTN.   
Dolezsar and colleagues (2014) conducted a comprehensive, systematic review to 
examine the association between racial discrimination and HTN.  Discrimination was 
assessed utilizing three validated tools.  In 44 articles averaging 742 participants per 
study, evidence suggested a small, significant association between perceived 
discrimination and HTN among hypertensive Black males with low education. 
Strengths of the study.   
(a) The title described the study phenomenon and identified the report as a 
systematic review.  (b) The abstract providing a concise summary.  (c) The literature 
review had adequate background information and rationale.  (d) The study aim was 
clearly stated.  (e) Inclusion and exclusion criteria appeared to be appropriate.  (f) Tables 
and figures were well-defined.  (7) Key study variables were operationalized.   
Weaknesses of the study.   
(a) The study lacked article synthesis (e.g., author’s name, year of publication, 
population, sample size, instruments, scores, confounders, outcome measures).  (b) The 
study lacked an objective finding describing the measurable effect of racial 
discrimination on SBP or DBP by mmHg.  Methodological weaknesses yield less 





Knowledge gap.   
No credible evidence showing the mean office BP or 24-hour ambulatory BP 
differences among diversional racial and ethnic groups can be found in the literature.   
Religious service attendance and blood pressure.   
Bell and colleagues (2012) conducted a descriptive, correlational, cross-sectional 
study to examine the association between religious service attendance (RSA) and BP 
among three ethnic groups.  Utilizing survey data from the 1994 National Center for 
Health Statistics, the study initially enrolled a total of 18,825 participants aged 20 or 
older through home interviews and medical examinations.  After excluding participants 
who were pregnant, had a heart attack, CHF, CVA and those who failed to answer an 
interview question regarding the frequency of RSA, 12,488 remained for the final data 
analysis.  Mean and proportional differences of RSA were compared utilizing t-tests and 
X2 tests.  Associations between RSA and HTN (yes/no), as well as SBP and DBP, were 
examined through logistic regression modeling.  The study found no relationship between 
RSA and HTN among Mexican-Americans, and RSA was inversely associated to SBP 
for all three ethnic groups (i.e., White, Black, Mexican-American), but more so for 
Whites and Blacks when compared with Mexican-Americans. 
Strengths of the study.   
The study addressed a sensitive yet important association between RSA and BP.  
The abstract provided a balanced summary of how the study was conducted and the 





readers to understand the statistical analyses performed in the study.  The study provided 
direction for future research on the topic.   
Weakness of the study.   
The study lacked clearly defined inclusion criteria and the design lacked a 
detailed description of (a) relevant dates (e.g., beginning and end, length of time needed 
to recruit 18,825 participants), (b) data collection procedures (e.g., who measured BP, 
brand of BP equipment), (c) 34% attrition rate, (d) confounders (e.g., social support, 
stress coping), (e) power analysis to justify N =12,488 for logistic regression model with 
three IV (i.e., ethnicity, RSA, sex), a major threat to statistical conclusion validity.  The 
reported statistical method of t-test for mean SBP and DBP differences among 3-ethnic 
groups, gender, and religious service attendance was questionable.  A more appropriate 
statistical analysis method should have been factorial multivariate analysis of covariance 
(MANCOVA).  If the author group conducted multiple t-tests, interpretation of the results 
would be at a high risk for type I error.  T-tests do not allow testing of interactions and 
main effects, but were reported in the tables, thereby making the chance of a type I error 
unlikely.  Finally, the study oversimplified the complexity of religion study.  It would 
have been more meaningful had religion construct were multidimensional rather than 
unidimensional as measured by church attendance only.  
Knowledge gap.  
Although much research has been conducted to examine relationships between 
religion and HTN, most studies have major methodological weaknesses yielding findings 





between religious involvement and BP could be found.  Per Gallup (2016), 70% 
Americans identify as Christian; 53% reported that religion was very important in their 
lives, suggesting a need to conduct research in this area.  Further study is needed to 
investigate the role of religion in BP control and/or HTN self-management as well as the 
impact of religious involvement on BP changes among VA and non-VA population 
comparison. 
HTN education program and blood pressure.   
Lauziere and colleagues (2013) conducted a quasi-experimental pilot study to 
investigate changes in SBP and DBP associated with a HTN education program.  
Participants were recruited from one physician’s office in Southeastern Canada between 
September 2008 and December 2010.  Participants were 20 to 70 years of age with HTN, 
French-speaking, no prior exposure to HTN education (e.g., HTN risk factors), and 
capable of participating in a HTN education program during the 6-month study.  Patients 
with DM, CVD, renal disease, and pregnancy were excluded from the study.  IVs were 
weight, BMI, WC, lifestyle (20-item instrument), quality of life (20-item instrument), 
dietary habit (15-item instrument); DVs were SBP and DBP.  Covariates or confounders 
were age, number of years since diagnosis of HTN, gender, level of education, household 
income, and employment status.  Statistical methods employed by the study included (a) 
t-tests and Fisher’s exact tests comparing the intervention and usual care group’s BP 
differences, (b) MLR to assess the change of BP within the HTN education intervention 
group from baseline to 6 months, (c) Poisson regression to assess change of physical 





polynomial logistic regressions to assess between group differences in smoking and 
alcohol use over a follow-up period.  The study found a significant reduction of SBP in 
the intervention group compared with the regular care group (p < .05) without between-
group differences in weight, BMI, WC, lifestyle, QOL, and dietary habits.   
Strengths of the study.   
The study title indicated the study design and HTN phenomenon.  The abstract 
provided a concise summary of the main features of the study report.  The introductory 
paragraph provided sufficient background and rationale for the study.  The purpose 
statement was well-defined and the methodology was described in detail.   
Weaknesses of the study.   
One obvious weakness of the study was the small sample size of the intervention 
group (n = 21) and regular care group (n = 19), which narrowed options of statistical 
analysis with MLR, Poisson regression, and LR models down to zero with five IVs.   
Lack of power associated with small sample size could explain the negative finding of 
between-group differences.  Another weakness appears to be biased higher baseline 
SBP/DBP in the intervention group compared with the regular care group, associated 
with systematic sampling without blinding procedure, allowing for a significant reduction 
in BP with medication therapy in the intervention group, not the usual care group.  The 
major confounder was not statistically controlled.  Additionally, the 20-item-lifestyle, SF-
36 quality of life, and 15-item-dietary habits instruments were not validated before they 
were used in the study.  Finally, an intervention of 6 months was too short to be credible 





Knowledge gap.  
The association between HTN education program and BP is limited.  
Functional disability and blood pressure.   
Qualitative study could reveal the phenomenon in which patients with functional 
disabilities cannot open antihypertensive pill bottles, thereby affecting one’s BP control.  
Quantitative study, however, has yet to associate this inability to one’s BP.  There has 
been no systematic review or meta-analysis on this topic.   
Insurance expansion impact undiagnosed and uncontrolled HTN.   
Hogan and colleagues (2015) conducted a secondary analysis utilizing data from 
the 1999-2012 National Health and Nutrition Examination Survey to examine 
associations between health insurance through the Affordable Care Act with the 
diagnosis and management of DM, dyslipidemia, and HTN.  The study sample consisted 
28,157 adults aged 20 to 64 years (52% male); 6,366 were diagnosed with HTN and 
1,531 with undiagnosed HTN.  Uncontrolled HTN was operationally defined per JNC-7 
guideline.  Diagnosed HTN was operationally defined by a “yes” answer to the question 
“have you ever been told by a doctor that you had high blood pressure?” (Hogan et al., 
2015, p. 1555).  Utilizing an epidemiologic data analysis strategy, this study found 
having health insurance was associated with a 9% higher probability of having a HTN 
diagnosis compared with uninsured people and insurance was associated with lower SBP 
(-2.9 mmHg) then people without insurance.  IRB oversight and approval was done by 





Institute of Diabetes and Digestive and Kidney Diseases (Grant No. 1R01 DK090435) 
and the first author was a member of the World Health Organization.   
Strength of the study.   
The abstract provided a precise summary of the features in the study report.  The 
study methodology was described in detail.  The statistical analysis method that utilized 
Mahalanobis’ distance to match variables for reducing potential confounders and match 
propensity scores for reducing risks of systematic sampling bias.  Confounders were 
statically controlled.  Sensitivity analysis separated private insurance from ACA coverage 
or non-insurance.  Results were appropriately represented.   
Weakness of the study.   
There was no power analysis to justify the sample size (N = 28,157) for the MLR 
model with four IVs (i.e., controlled HTN, uncontrolled HTN, A1C, total cholesterol), a 
threat to statistical analysis validity.  The SBP difference between insured to uninsured 
cases could be clinically irrelevant.      
Knowledge gap.   
No knowledge gap; however, there is a need for risk-benefit analysis associated 
with treating elders at BP goal (140/90 mmHg).  There is also a need to analyze the 
benefit of treating pre-HTN and conduct a cost analysis associated with pre-HTN 
treatment (Moise et al., 2015).   
Copayment and medication adherence.   
Sinnott and colleague (2013) conducted a systematic review and meta-analysis to 





copayments.  This is relevant because adherence to antihypertensive medication has been 
associated to HTN-treatment success in RCT (Alhalaiqa, Deane, Nawafleh, Clark, & 
Gray, 2012).  The analysis comprised four studies of Medicare insurance plans and three 
studies of copayment increase in the VA healthcare system in older men and women (M 
= 72 years, Range = 65-85 years) with copayments from $5-7$.  This study found 
significant evidence of non-adherence to medicines among Medicare and VA insured 
beneficiaries where copayments for medications were necessary (OR = 1.11, 95% CI 
[1.09, 1.14], p < .001).   
Strength of the study.   
(a) The study title was a systematic review and meta-analysis.  (b) The abstract 
provided a concise summary of the features in the study report.  (c) The methodology that 
covered detailed eligibility criteria, information sources, search strategies, study 
selection, data collection processes, summary measures, synthesis of results, and risk of 
bias across studies.  (d) Results were detailed and appropriate.  (e) The discussion was 
detailed, balanced, and candid.  (g) The study resulted in important policy implications, 
was trustworthy, and was relevant to the veterans’ population. 
Weakness of the study.   
No major validity concerns could be seen. 
Knowledge gap.   
A new knowledge gap was identified with this systematic review and meta-
analysis: the association between socioeconomic status and non-adherence to 





measures (Alsabbagh et al., 2014).  To fill this gap, research for HTN control should 
collect actual income and copayment data rather than nominal or ordinal data as HTN has 
a higher prevalence in low-to-moderate socioeconomic groups.   
Lifestyle as a variable impacting veterans’ HTN control. 
Smoking and arterial stiffness.   
Scallan and colleagues (2010) conducted a systematic review to assess a 
combined effect of HTN and smoking on arterial stiffness, considering the role of large 
arteries in the circulation of blood to the periphery.  In the study reviewing four articles 
published between 1985 and 2008 in English, HTN and smoking were independent 
detrimental factors for raising arterial stiffness; the combined effects were even greater.   
Strengths of the study.   
(a) The study addressed a public health concern.  (b) The introductory paragraph 
provided sufficient background information and rationale for the review.  (c) Inclusion 
criteria were clear and strict, decreasing the risk for biased outcomes.  (d) Figures and 
tables stood alone.  (e) The study reviewed both the acute and chronic effects of smoking 
on arterial stiffness.  (f) Major confounders were statistically controlled in addition to 
strict inclusion criteria.  (g) Conclusions included the need for future research.  
Weaknesses of the study.   
(a) The study title did not identify the report as a systematic review.  (b) The 
abstract lacked description of the data source and study participants.  (c) The efforts from 
following up the reference lists, personal contacts with experts, searching for unpublished 





relevant studies were included.  (d) The four articles reviewed were all cross-sectional; 
the study would have been stronger if at least one RCT article were included in the 
review.  (e) The study lacked evidence of assessing individual article quality and overall 
publishing bias.  Higher quality systematic review and/or meta-analysis on the topic 
would improve trustworthiness.   
Knowledge gap.   
Study is needed to examine smoking cessation therapy combined with the 
appropriate antihypertensive medication for greater improvement of arterial stiffness 
among veteran smokers with HTN. 
Smoking and blood pressure.   
Despite smoking being listed as an independent risk factor of essential HTN by 
multiple JNC guidelines, no systematic review or meta-analysis has examined the 
association between smoking and BP among any population in the literature.  Existing 
studies were primarily cross-sectional surveys; major findings supported the notion that 
smoking or chewing tobacco affected BP (Hughes, Leong, Sothy, Lun, & Yed, 1993) or 
did not affect BP (Li, Tong, Wang, Lin, & Zhang, 2010; Pandey, Shreevastva, & 
Neupane, 2014; Thuy et al., 2010).  Few interventional or longitudinal studies on this 
topic could be found in scientific literature.   
Alcohol and blood pressure.   
Briasoulis and colleagues (2012) conducted a systematic review and meta-
analysis to determine the effects of dose-response alcohol consumption on the long-term 





studies (N = 33,904 men) were chosen from the databases of MEDLINE, PubMed, 
Embase, and Cochrane Library for Central Register of Clinical Trials (Briasoulis et al., 
2012).  This study found a dose-response alcohol consumption between 10 gm /day and 
11-20 gm /day tended to increase the risk of HTN (RR = 1.03, 95% CI [0.94, 1.13], p 
= .51; RR = 1.15, 95% CI [0.99, .33], p = .06, respectively) and that heavy drinkers (31-
40 gm/day) was significantly associated with an increased risk of HTN (RR = 1.77, 95% 
CI [1.39, 2.26], p < .001). 
Strength of the study.   
(a) The study addressed a clearly-focused dose-response alcohol consumption and 
HTN risk.  (b) The bibliographic databases used were credible and inclusive of all 
important studies.  (c) Inclusion and exclusion criteria were included.  (d) A quality 
assessment of all included studies was performed.  (e) The authors of reviewed studies 
were contacted if data was unclear; publication biases were checked and found to be low 
risk.  (f) Findings were presented with odds ratio and 95% CI, precise, and valid 
including consistency with several prior studies. 
Weakness of the study.   
(a) The inclusion of studies using 160/95 mmHg as HTN definition reduced the 
number of HTN cases, biasing results away from the null hypothesis; a threat to internal 
validity.  (b) Measuring alcohol consumption by grams per day was less common than 
drinks per day; however, it is a more accurate measure.  The study results are less 





Knowledge gap.   
(a) Excessive alcohol consumption and alcohol withdraw could raise BP and HR 
significantly in patients going through alcohol overdose and detox.  (b) There is a lack of 
consensus for measuring alcohol consumption in terms of units.   
DASH diet and blood pressure.   
Saneei and colleagues (2014) conducted a systematic review and meta-analysis of 
17 RCTs with 2,561 participants to assess the magnitude of the DASH diet on adults’ BP.  
This study reported that the DASH diet significantly reduced SBP by 6.74 mmHg (95% 
CI [-8.25, –5.23], I2 = 78.1%), DBP by 3.54 mmHg (95% CI [-4.29, -2.79], I2 = 56.7%) 
with the mean baseline SBP and DBP explaining 24% and 49% of the variance among 
the studies.   
Strengths of the study.   
(a) The abstract summarized the main features of the study.  (b) The literature 
review provided sufficient background knowledge, rationale, and aims for the review.  (c) 
The study followed a preferred reporting for systematic review and meta-analysis 
(PRISMA) protocol.  (d) Inclusion and exclusion criteria were clearly elucidated.  (e) 
Multiple databases were searched and the searching strategy was described clearly.  (f) 
Figures and tables were clear and distinct.  (g) The risk of publication bias was checked.  
(h) Results contributed significantly to HTN research databases. 
Weaknesses of the study.   





Knowledge gap.   
None could be identified. 
Physical activity and blood pressure.   
Semlitsch and colleagues (2013) conducted a systematic review and meta-analysis 
to evaluate the long-term effects of increasing physical activity comparing with no 
activity in adults with essential HTN.  Outcome measures were all causes of mortality, 
cardiovascular morbidity and mortality, end stage renal disease, quality of life, and 
adverse events.  This study has included three high-quality, systematic reviews published 
between 1997 and 2009.  Additionally, included were nine RCTs with at least 24 weeks 
of follow-up evaluation for the effects of increased physical activity on BP among adults, 
published by September 2012.  This study was unable to form definitive conclusions 
regarding the effects of increasing physical exercise on BP because of the following 
limitations: (a) 50% of the included RCTs had small sample sizes, approximately 20 
participants per group; (b) more than two-thirds of the studies included RCTs found to be 
at high risk for bias. 
Strengths of the study.   
(a) The abstract provided a concise summary of the main features of the report.  
(b) Utilized traditional methodology without deviation from the standards for a 
systematic review and meta-analysis.  (c) The presentation of results included tables that 
were of sufficient detail and quality.  (d) Discussion was thorough, balanced, and candid.  





Weaknesses of the study.   
Minimal risks for bias or threats to validity were found in the study. 
Knowledge gap.   
Figures illustrated that high quality studies were rare; approximately 99% of 
studies were low in quality.  Nonetheless, the effects of increasing physical activity on 
BP reduction among hypertensive individuals remained unknown.  High quality RCTs 
are needed with large sample sizes to exam the effects of physical exercises on CV risks 
and benefits among hypertensive individuals.   
Coffee, blood pressure, and cardiovascular disease risk.   
Mesas and colleagues (2011) conducted a systematic review and meta-analysis to 
assess (a) the acute and long-term effect of caffeine and coffee intake on BP and (b) the 
association between habitual coffee consumption and risk of cardiovascular disease 
among hypertensive individuals.  The study included five trials examining the acute 
effects of caffeine on BP, three trials exploring the long-term effects of coffee intake on 
BP, and seven cohort studies investigating the association between habitual coffee 
consumption and cardiovascular events, all published by April 2011.  The study 
concluded that caffeine intake produced an acute increase in BP for 3 hours or more, but 
there were no association between long-term or habitual coffee consumption and an 
increased BP or risk of cardiovascular disease in hypertensive individuals.   
Strengths of the study.   
(a) The abstract provided a precise summary of the features of the study report.  





for doing the study.  (c) The study methodology followed PRISMA and MOOSE 
protocol.  (d) The key variable of HTN was operationally defined based on JNC-7 
(Chobanian et al., 2003).  (e)  The figures and tables were clear and independent.  (f) 
Results were detailed and depicted each study sample’s characteristics for which data 
were extracted.  (g) The study had strong external validity with no publication bias, per 
Begg’s funnel plot and Egger’s test.  (h) The conclusion that coffee intake had no long-
term effect on BP was consistent with the findings of another meta-analysis (Zhang, Hu, 
Caballero, Appel, & Chen, 2011).  (i) The study results included important practice 
implications, suggesting that the practitioner ask about caffeine intake prior to measuring 
the patient’s BP. 
Weakness of the study.   
(a) The unit of coffee intake in milligrams was uncommon in the literature and 
difficult to measure in everyday experience.  (b) Mechanisms of caffeine raising BP for 3 
hours or more after ingestion (dose-response) was not elaborated further in the review.   
Knowledge gap.   
(a) The need to study the dose-response relationship between coffee intake and 
BP increase among VA and non-VA patients is indicated.  (b) The effects of coffee or 
caffeine on the degree of BP control among hypertensive patients should include possible 
variations in the type of antihypertensive medication (e.g., ACEI, CCB, BB) as such 
evidence could help adapt recommendations about coffee consumption in hypertensive 





Job strain and ambulatory blood pressure.   
Landsbergis and colleagues (2013) conducted a meta-analysis and systematic 
review to assess the relationship between job strain and ambulatory BP.  The study 
reviewed 29 articles, including 22 cross-sectional, one case control, and three cohort 
studies.  This study found that a single exposure to job strain was associated with higher 
work SBP (3.43 mmHg; 95% CI [2.02, 4.84]; p < .001; I2 = 62.3) and DBP (2.07 mmHg; 
95% CI [1.17, 2.97]; p < .001; I2 = 42.3).  Associations were stronger in men versus 
women and in studies of broad-based populations with limited occupational variance; the 
study suggested that job strain be assessed to reduce one’s CV risk. 
Strengths of the study.   
(a) The title identified the main study phenomenon, meta-analysis, and systematic 
review.  (b) The methodology followed traditional meta-analysis protocol as well as 
being thorough and balanced.  (c) The presentation of results was clear and precise.  (d) 
The discussion was fair and balanced.  (e) Directions for future research were offered.  (f) 
The study result is trustworthy.   
Weaknesses of the study.   
The abstract was missing background, objective, data source, study eligibility 
criteria, participants, intervention, study appraisal, and synthesis method.   
Knowledge gap.   





Secondary HTN impacting veterans’ HTN control. 
Obstructive sleep apnea and systolic blood pressure.   
Kong and colleagues (2016) conducted a systematic review and meta-analysis to 
evaluate an association between markers of metabolic syndrome and OSA.  A total of 10 
articles in the review were the most up-to-date evidence published by the end of 2015.  
This study found that patients without OSA had lower SBP compared with those who did 
have OSA (pooled SMD = 0.56; 95% CI [0.40, 0.71]).  The study also found that patients 
with OSA had lower HDL (pooled SMD = -0.27; 95% CI [-0.38, -0.16]; p < .001) and 
higher LDL (pooled SMD = 0.26; 95% CI [0.07, 0.45; p < .05).  In addition, OSA was 
associated with an increased triglyceride (pooled SMD = 0.26; 95% CI [0.07, 0.45]; p 
< .05) and FBG (pooled SMD = 0.35; 95% CI [0.81, 0.53], p < .001).  OSA was 
significantly associated, not only with SBP elevation, but also four lab components (i.e., 
HDL, LDL, triglyceride, FBG) suggesting that OSA is associated with metabolic 
syndrome.   
Strengths of the study.   
(a) The abstract described the features of the study report clearly and precisely.  
(b) The introductory paragraph clearly described the rationale and objectives for the 
review.  (c) The study followed PRISMA protocol. (d) Sensitivity analysis demonstrated 
good reliability in study results in the relationship between OSA and SBP without 






Weaknesses of the study.   
(a) There was a potential publication bias for the associations between OSA and 
lab parameters.  (b) The form and effect size of the association between OSA and SBP 
were not analyzed, likely due to a small sample size.   
Knowledge gap.   
The relationship between SBP (< 140 mmHg, ≥140 mmHg) and a diagnosis of 
OSA based on the ICD-9-CM code among veterans remains unknown.   
HTN comorbidity impacting veterans’ HTN control. 
Impact of exenatide (Byetta) on HgA1C, weight, and blood pressure.   
Paul and colleagues (2012) conducted a post-hoc analysis to examine the synergy 
between improved glycaemia, weight loss, and BP reduction in patients treated with 
either exenatide (Byetta®) twice daily (BID) or once weekly (OW).  Byetta® was 
manufactured by AstraZeneca.  The study sample consisted of 686 subjects (53% men; 
Mage = 55 years, SD = 10; Mweight = 95 kg, SD = 20; MSBP/DBP = 130/79 mmHg, SD = 
15/9; MHgA1C = 8.3%, SD = 11%) treated with exenatide QW (n = 541) or BID (n = 145) 
over 26 weeks.  Patients were divided into four groups at each visit by glycaemia and 
weight response; those who failed to reduce both A1C and weight below weight means 
became the reference group.  The other three groups were A1C reduction, weight 
reduction, and both A1C and weight reduction.  Compared with the reference group, the 
study reported a significant likelihood of improving SBP (< 130 mmHg) by 88%, 61%, 
and 30% respectively.  The likelihood of improving DBP (< 80 mmHg) was 63%, 45%, 





Strengths of the study.   
(a) The study explained mechanisms of action regarding the glucagon-like 
peptide-1 (GLP-1) receptor agonist exenatide.  (b) Tables helped the reader visualize 
various data distributions among groups.  (c) The study explained beneficial effects of 
exenatide in weight reduction, reduced A1C, and reduced BP. 
Weakness of the study.   
(a) Exenatide has not been approved as a drug of choice by the U.S. Food and 
Drug Administration (FDA) for its BP lowering effect.  (b) The reference group, by its 
design, appeared to be inappropriate as it reported exenatide more effective in the 
reduction of A1C and weight, more so than a true control group with no exenatide 
treatment; this could be misleading. (c) Exenatide had multiple side effects, was costly 
for patients with no health insurance or high copayments as exenatide was classified as a 
third-tier drug for the treatment of diabetes.  (d) The likelihood of BP reduction was 
poorly explained. 
Knowledge gap.   
There was no correlational study to examine the association between A1C and 
SBP/DBP among veterans in the literature.   
HDL and blood pressure.   
There was no correlational study to examine the association between HDL and 






Obesity (BMI ≥30) and blood pressure.   
Neto and colleagues (2013) conducted a cross-sectional survey to evaluate 
relationships among BMI, waist circumference, waist-hip ratio, waist stature ratio, 
conicity index, body adiposity index and BP in northeastern Brazil.  The study sample 
consisted of 316 community-dwelling adults aged 60–105 years old (M = 74 years, SD 
=10).  This study found that BMI and the body adiposity index were significantly 
associated with male HTN, suggesting these measures be used to screen HTN in the 
elderly men. 
Strengths of the study.   
(a) Research was needed for this research question.  (b) The purposive sampling 
method was appropriate for the research questions asked.  (c) The sample size was 
adequate for the Poisson and AUROC model used by the study. 
Weaknesses of the study.   
(a) There was a lack of evidence ensuring BP data accuracy as 20 students were 
used to collect the BP data.  (b) The sensitivity (39.3%) and specificity (82.1%) of BMI 
for detecting HTN did not meet the minimum standard for a clinical measure.  (c) 
Measurements of alcohol (i.e., ≥1 time/week or < 1 time /week) was not helpful in 
evaluating its impact on BP due to metabolic turnaround time.  The results would be 
considered untrustworthy.   
Knowledge gap.   





BMI and BP in diverse populations.   
Abayomi (2012) conducted a meta-analysis to examine the relationship between 
BMI and SBP among diverse populations.  The study found that the relationship between 
BMI and SBP could be linear or curvilinear, and was dependent upon the statistical 
models used.  The study concluded that those relationships were weak among differing 
populations and age was not a confounder in that relationship.   
Strengths and weaknesses of the study.   
This PhD student’s dissertation project was diligent and likely conducted under 
the supervision of academic advisors.  No major methodological weaknesses were found.  
The study result was trustworthy.   
Knowledge gap.   
The relationship between BMI and SBP was weak, both linear and curvilinear, 
depending upon the statistical models used; an interesting starting point for this topic.   
Mental health disorder impacting veterans’ HTN control. 
Depression and HTN.   
A systematic review and meta-analysis found the prevalence rate of depression in 
patients with HTN (26.8%; 95% CI [21%, 32.3%]; Li, Li, Chen, Chen, & Hu, 2015).  A 
second systematic review found that late-life depression, defined as a depressive illness 
in people aged 60 years or older, was significantly associated with hypotension rather 
than HTN (Briggs, Kenny, & Kennelly, 2016).  There was no credible evidence showing 






Anxiety and HTN.   
Pan and colleagues (2015) conducted a systematic review and meta-analysis.  A 
total of 21 articles were reviewed as the most up-to-date evidence by November 2014.  
The study found a significant association between anxiety and HTN (OR 1.18; 95% CI 
[1.02, 1.37], p < .001) from analyzing 13 cross-sectional studies and 8-prospective 
studies (adjusted HR 1.55; 95% CI [1.24, 1.9]; p < .001).  This study concluded that 
anxiety, as an independent risk factor for HTN, required early detection and treatment 
among patients with essential HTN. 
Strengths of the study.   
(a) The study was a systematic review and meta-analysis.  (b) The abstract 
described the feature of the study report clearly and precisely.  (c) The introductory 
paragraph described the rationale and objective for the review clearly and adequately.  (d) 
The study following the PRISMA protocol. (e) There was a strong evidence of an 
association between BP and anxiety.  (f) The mechanisms of the relationship found by the 
study were discussed in detail.  (g) The study suggested to use DSM-IV (GAD-7) to 
assess anxiety.   
Weaknesses of the study.   
(a) The study included only English- and Chinese-language articles and could 
have influenced pooled results.  (b) The study was unable to analyze raw data, limiting 
adjustment to many of the factors at the granular level and ultimately could have 
influenced pooled results.  (c) Measurement instruments for anxiety differed among the 





sectional, pooling data could produce similar outcomes but be of questionable accuracy.  
(d) Anxiety is a treatable disease; its impact on BP could be dynamic.  Interpreting and 
applying study results should be done with caution. 
Knowledge gap.   
It is important to explore the short-term and long-term effects of anxiety on HTN 
in terms of BP, CV risk factor (e.g., age, smoking, alcohol, sedentary, diet), and end-
organ damage (e.g., brain, heart, kidney).   
PTSD and blood pressure.   
Paulus and colleague (2013) conducted a retrospective EMR data analysis to 
examine if patients with PTSD had higher SBP, DBP and HR compared with non-PTSD 
patients, as well as a relationship between trauma exposure and BP within the Iowa City 
VA Healthcare System.  The study sample consisted of veterans with co-morbidities of 
depression, mood disorder, anxiety, smoking, and/or substance abuse in men (MPTSD = 26 
years, n = 88; Mnon-PTSD = 32 years, n = 98).  The study found significant differences in 
veterans in the PTSD group in DBP (M = 87.6, SD = 6.3) compared to the non-PTSD 
group (M = 78.4, SD = 7.2; Cohen’s d = 1.36 [large]) and in SBP between the PTSD 
group (M = 133.8, SD = 8.6) compared to the non-PTSD group (M = 122.3, SD = 9.6; 
Cohen’s d = 1.27 [large]).  This study also found that trauma-exposed patients without 
PTSD had significantly higher BP than non-exposed ones.   
Strengths of the study.   





Weaknesses of the study.   
(a) Major confounders (e.g., anxiety, antidepressants for patients with mood 
disorder) were not statistically controlled, a major threat to PTSD construct validity.  (b) 
The study lacked explicit exclusion criteria, a threat to internal validity.  (c) No power 
analysis was reported to justify the sample size for the two-sample t-test and the 
ANCOVA, a major threat to statistical validity.  (d) Key concepts were not operationally 
defined (e.g., PTSD by ICD-9-CM code, psychiatric medication, notes, trauma exposure), 
a threat to internal validity.  The combination of methodological weaknesses made the 
study untrustworthy. 
Knowledge gap.   
There was no systematic review and/or meta-analysis to explore the relationship 
between PTSD and SBP/DBP with the most up-to-date evidence.   
Medication impacting veterans’ HTN control. 
Effectiveness of antihypertensive medication.   
Fretheim and colleagues (2012) conducted a systematic review and meta-analysis 
to evaluate which antihypertensive medication class was the most effective in reducing 
the incidence of CVD outcomes for healthy people at risk.  Results from this study could 
assist in developing clinical recommendations for a first-line drug choice to prevent CVD 
supported by study findings.  A total of 25 articles was reviewed with the most up-to-date 
RCT evidence through February 2011.  The study found no particular drug to be more 





was little or no difference between commonly used blood pressure lowering medications 
for primary prevention of CVD. 
Strengths of the study.   
(a) The study title suggested important HTN control phenomena as a systematic 
review and meta-analysis.  (b) The abstract captured the main features of the study report.  
(c) The methodology followed traditional systematic review and meta-analysis protocol 
with clear inclusion and exclusion criteria; the study was registered (PROSPERO 
CRD42011001066).  (d) Results included self-explanatory tables with narrative.  (e) 
Critique of prior studies was fair and balanced; the study’s own limitations were 
discussed in detail.   
Weaknesses of the study.   
No major validity concerns could be identified. 
Knowledge gap.   
The results appeared to conflict with the drug treatment algorithm recommended 
by JNC-7; however, the trustworthiness of this study is compelling. 
Providers’ assessment of adherence and intensification of BP medication.   
Meddings and colleagues (2012) conducted a cross-sectional survey to answer 
two research questions: How often did providers correctly identify patients with poor 
adherence to chronic BP medication? and, how often did providers intensify BP 
medication regimen on patients with significant non-adherence issue when BP was 
uncontrolled?  The sample consisted of 92 primary care providers and 1,169 veterans (M 





was collected on BP, at the time of study enrollment via automated data sources; 
medication adherence, from VA pharmacy records 1-year prior and 90-day post-
enrollment with refill history for antihypertensive medication classes; provider-survey 
post patient visit; and demographic questionnaire post patient’s clinic visit.  Medication 
non-adherence was based on a gold standard of continuous multiple-interval gap (CMG), 
where non-adherence was defined as 20% CMG or greater. The patient would be non-
adherent if the medication was missed 1 in 5 doses or more on average.  The study found 
an overall poor correlation between providers’ assessment of a patient’s adherence and 
the patient’s refill adherence (r = .18, p < .001; Kappa = .15).  The study also found that 
BP medications were not available for 20% or more days in medication non-adherence 
patients.  Providers characterized 37% of 211 patients as medication non-adherence.  
Among 18 patients with non-adherence 50% or more of the time, the provider assessed 
44% as non-adherence.  Providers intensified antihypertensive medications in 451 of 
patients (42%) regardless their medication adherence status.  
Strengths of the study.   
(a) This study addressed a clinically significant issue.  (b) Data collection was 
from multiple sites, increasing the external validity of study results.  (c) Key variables 
were operationally defined.  (d) Missing data were imputed to prevent sampling bias.  (e) 
Figures and tables were clear and independent.  (f) Sampling characteristics were like 







Weaknesses of the study.   
There was no power analysis presented to justify the sample size for the logistic 
regression model employed by the study. 
Knowledge gap.   
The authors made multiple references for a need of a reliable, multidimensional 
HTN treatment adherence instrument. 
Number of doctor’s office visits and HTN control.   
There were no correlational studies, systematic review, or meta-analysis to 
explore the relationship between the number of doctor’s office visits and SBP/DBP.   
Impact of antihypertensive drug therapy on cognitive decline and dementia.   
Rouch and colleagues (2015) conducted a systematic review to examine all 
published studies investigating the relationship between antihypertensive drug therapy 
and cognitive decline or dementia).  A total of 38 articles were included in the review 
from 1990 to 2014.  A quality assessment of all articles was conducted by Jadad criteria 
(Pogue et al., 1996).  The study concluded that antihypertensive drug therapy might 
decrease the incidence and progression of cognitive decline, dementia, and Alzheimer’s 
disease, specifically calcium channel blockers and renin-angiotensin system blockers.   
Strengths of the study.   
(a) The study addressed the effects of antihypertensive drug therapy on cognition, 
dementia, and Alzheimer’s disease.  (b) The flowchart for the systematic review clarified 
the process of article selection.  (c) The tables were helpful in reviewing relevant study 





explanation of the mechanisms with dementia prevention in the discussion section was 
extensive. (f) This study results were consistent with another meta-analysis, with one 
exception: antihypertensive drug use did not decrease the risk of developing Alzheimer’s 
disease, associated cognitive decline, or cognitive impairment (Chang-Quan et al., 2011). 
Weaknesses of the study.   
(a) There was a lack of homogeneity in all the reviewed articles across study 
designs, patient populations, variables, duration of follow-up, and methodology quality 
impacting the estimation of effect size.  (b) Antihypertensive medication dosage varied 
study-to-study and most studies did not address the medication adherence issue, creating 
an issue with the reliability of study findings.  The overall results lacked a definitive 
conclusion. 
Knowledge gap.   
The effects of CCB and ACEI on cognitive function, dementia, and Alzheimer’s 
disease with 5 years or greater follow up among veterans’ and non-veteran population 
will be needed to confirm the study results.   
Uncontrolled HTN impacting veterans’ quality of life. 
Impact of non-adherence on end-organ damage.   
Gosmanova and colleagues (2015) conducted a cohort study with an 8-year 
follow-up to examine the association between ICD-9-CM code V 15.81 (non-adherence) 
and end organ damage (EOD) involving the heart, brain, and/or kidneys among 312,489 
veterans with newly diagnosed HTN.  The study sample was obtained from a prior HTN 





1.73 m2), initiated on one or more antihypertensive drugs in the outpatient setting from 
October 1, 2004 through September 30, 2006, based on VA pharmacy dispensation 
records.  Patients who used combined drug therapy, on α-blocker monotherapy and with 
an ICD-9-CM code for CHF and tachyarrhythmia were excluded from the study.  
Outcome data, including demographic, laboratory, SBP/DBP, and comorbidity, were 
collected.  Patients were divided into two groups (inadequate or < 80% vs. adequate or 
≥80%) based on their adherence to antihypertensive drug as estimated by medication 
possession ratio (MPR) per VA standard formula.  Follow up for brain damage with 
stroke by ICD-9-CM codes and Current Procedure Terminology (CPT) codes, heart 
damage with coronary artery bypass grafting (CABG), CAD and percutaneous 
angioplasty, and kidney damage with GFR, study found that ICD-9-CM code V 15.81 
independently predicted the incidence of stroke, CAD, CKD, and end stage renal disease. 
Strengths of the study.   
The study addressed an association between V 15.81 code and EOD among 
veterans with essential HTN.  Major confounders were statistically controlled.   
Weaknesses of the study.   
There was no power analysis to justify the sample size for the Cox regression 
analysis of five independent variables (i.e., GFR, CKD, ESRD, CAD, stroke) used by the 
study, a major threat to statistical conclusion validity affecting the trustworthiness of the 






Knowledge gap.   
A high quality, longitudinal study of HTN-associated EOD of the brain, heart, 
and/or kidney with quantitative measurements of medication adherence and BP at yearly 
follow up intervals for 7 to 8 years is needed. 
Summary 
In summary, several major themes emerged.  First, essential HTN control is a 
multidimensional issue associated with (a) patients’ consumption of excessive amounts of 
salt, alcohol, caffeine products (Briasoulis et al., 2012; Chobanian et al., 2003; Neter et 
al., 2003, Soltani et al., 2016), flaxseed (Khalesi et al., 2015), and lack of physical 
exercise (Lee & Wong, 2015), smoking related arterial stiffness (Scallan et al., 2010), 
illness of anxiety (Pan et al., 2015), metabolic syndrome, obesity (Kong et al., 2016), 
knowledge of HTN disease or HTN risk factor and external support (Lahdenperä & 
Kyngäs, 2001; Schmid et al., 2009), (b) providers’ attitudes in following JNC-7 
guideline, time constraints, frustration with patients’ refusal to comply with medical 
advice and missing scheduled appointments, HTN treatment guideline regarding to BP 
treatment goal, (c) environmental factors, including health insurance, copayment (Sinnott 
et al., 2013), job stress (Landsbergis et al., 2013) and BP treatment goals per HTN 
treatment guideline, (d) antihypertensive drug effectiveness and adherence (Hultgren et 
al., 2014; Schmid et al., 2009) and (e) end organ damage including CVA, TIA, vascular 
dementia, CHF, CAD, MI, CABG, and CKD.  Second, HTN-control research remains in 
an infancy stage as scientists continue to seek an optimal SBP goal for hypertensive 





lacks a theory-based, operational definition of patients’ adherence to HTN-control 
protocol and HTN control outcomes (e.g., BP, HR, BMI, WC, cholesterol values, blood 
sugar values, kidney function values, CVA, TIA, CHF, CAD, MI, CKD, quality of life) 
based on current HTN treatment guidelines.  Fourth, much of the current HTN control 
studies have serious methodological weakness with non-probability sampling and cross-
sectional observational study design as the most commonly used ones without any 
theoretical or conceptual basis, producing less than credible and useful results.  Fifth, 
most results in systematic reviews and meta-analyses were based on RCTs that lasted less 
than a year and requires more longitudinal RCTs in the future.  Sixth, major knowledge 
gaps remain about the association of family history in premature CVD and how that 
affects offspring BP.  Seventh, there is a lack of evidence in the associations between IVs 
(e.g., age, sex, race, religion, A1C, HDL, BMI, MDD, GAD, PTSD) and a DV (SBP) 
among veterans.  The study was intended to address the multidimensional factors 











1. What is known? 
• DASH significantly reduced weight in 8-week to 1-year by -1.42 kg/m2 (95% CI,  
-2.03 to -0.82), BMI -0.42 kg/m2 (95% CI, -0.64 to -0.20) & Waist Circumference 
-1.05 cm (95% CI, -1.61 to -0.49).  
• Weight reduction of -5.1 kg (95% CI, -6.03 to -4.25) reduced SBP by -4.44 mmHg 
(95% CI, -5.93 to – 2.95) and DBP by -3.57 mmHg (95% CI, -4.88 to -2.25). 
• Sedentary behavior per day was associated with 0.06 mmHg increase in (95% CI, 
0.01-0.11, p<0.05) SBP and 0.20 mmHg (95% CI, 0.10-0.29, p<0.001) in DBP. 
• DASH significantly reduced SBP by 6.74 mmHg (95% CI: -4.29 to – 2.79, I2 = 
56.7%), DBP by 3.54 mmHg (95% CI: -4.29 to -2.79, I2 = 56.7%). 
• Caffeine intake produces an acute increase in BP for ≥ 3 hours, but there were no 
associations between long-term or habitual coffee consumption and HTN or CVD 
risk. 
• Patients without the OSA had a lower level of SBP compared with those who had it 
(pooled SMD = 0.56, 95% CI, 0.40 to 0.71). 
• Job strain is significantly associated with ambulatory BP. 
• Anxiety is significantly associated with HTN. 
• Alcohol consumption/AUDIT-C score is significantly associated with BP. 
 
2. What is unknown? 
• An optimal goal of SBP for patients with HTN.  
• The association between insurance copayment and number of hypertension visit.  
• The association between age and BP (forms and strengths). 
• Sex difference in risk of cardiovascular disease and mortality. 
• The association between racial discrimination and BP. 
• The association between religious involvement and BP. 
• The association between a HTN education program and BP. 
• The association between veterans’ functional ability and BP. 
• The association between adolescents’ BP and adults’ BP. 
• The association between number of cigarettes smoked today and BP today. 
• The association between number of years smoked and BP trend by years smoked 
• The association between chronic stress (job strain) and BP (office BP x 4). 
• The association between MDD/PHQ-9 score and BP. 
• The association between PTSD/PCL-M score and BP. 
• The association between GAD/GAD-7 score and BP. 
 
3. What the study adds? 
• Characteristics of hypertensive veterans in a Southern California primary care clinic.   
• Self-reported medication adherence is an independent predictor for one’s SBP.   
• Many insights into conducting secondary analysis with electronic medical records 
(EMRs) that may help novice researchers with this approach in the future.  
  
 





Chapter 3: Methodology 
This chapter presents research methodology including study design, setting, 
sample, and source of data for the study.  It also presents sampling method, data 
collection procedure, sampling size with power analysis and statistical analysis 
procedure.  The conclusion addresses issues for the protection of human subjects.  
Study Design 
The study is a descriptive, exploratory, cross-sectional, retrospective, convenient 
sampling of an EMR data set analysis.  The design was approved by the researcher’s 
dissertation committee for four reasons.  First, laboratory data (i.e., A1C, HDL) cannot be 
obtained by interview, survey questionnaire, or other observational methods.  Second, it 
reduces resources by utilizing a pre-existing data.  Third, it is time efficient when the 
needed information is readily available and easily found.  Fourth, research questions are 
in accordance with the protection of cases under study.   
Study Setting 
The study was conducted at a Southern California VA primary care clinic for 
approximately one month from October 17, 2016 through November 15, 2016.   
Sample and Source of Data  
The study sample comprised U.S. veterans with essential HTN based on ICD-9-
CM code 401.  Data used in this report were from a VA dashboard data set at a Southern 
California VA primary care clinic between October 17, 20014 and October 17, 2016.  
The data set was used by providers to identify and monitor veterans with chronic disease 





Inclusion criteria.   
Men and women veterans of any race, 24-years-old and above with essential HTN 
and multiple comorbidity, with or without antihypertensive drug therapy.   
Exclusion criteria.   
Missed a baseline or final point of BP measurement, or had an organ transplant 
and on steroid drug therapy.   
Sampling Method 
A convenience sampling method was used as it entailed using the most readily 
available data to answer study questions and achieve the study objective at the time of 
data collection.  More specifically, study cases already existed in an EMR dashboard at 
the time of data collection.   
Data Collection Procedure 
1. An expedited Institution Review Board (IRB) was granted because the research 
collected pre-existing data without any procedure involvement. 
2. Study oversight was determined by IRB at the University of San Diego and the 
Department of Veterans Affairs VA Healthcare System, California. 
3. A data extraction instrument was created based on the HTN control conceptual 
framework (see Appendix B).   
4. Retrospective data was collected by the researcher utilizing Microsoft Excel, then 





5. The researchers carefully reviewed the cover sheet, problem list, medication list, 
order list, providers’ notes, lab values, reports of BMI and BP measurement of the 
EMR covering two years, from October 17, 2014 through October 17, 2016.   
6. Data collection took place in a private office at a Southern California VA primary 
care clinic began at 8:00 AM and ended 5:00 PM, Monday through Friday, from 
October 17, 2016 through November 15, 2016.   
7. All harvested data was pre-coded to protect veteran cases’ confidentiality.   
8. The harvested data was then mailed to the researcher’s password-protected e-mail 
account electronically and stored on a flash drive.   
9. Data accuracy was to be ensured with a random check of 33% data by a nurse 
practitioner who is blinded to the study with an acceptable accuracy of Cohen’s 
Kappa ≥ 0.81.   
Sample Size and Power Analysis 
1. The minimum sample size was 97 for the multiple linear regression (MLR) model 
employed by the study per a priori sample size calculator with effect size (r2) = 
0.15, statistical power = 0.8, predictor variable = 6 (i.e., A1C, HDL, BMI, BP 
medications, clinic visit, baseline SBP) and probability = 0.05 (Soper, n.d.). 
2. The minimum sample size was 300 for a logistic regression model (LRM) 
employed by the study based on 50 cases per IV principle (Polit, 2012).  The 
LRM was utilized to explore non-normally distributed IVs (i.e., A1C, HDL, BMI, 
baseline SBP) associated with a dichotomous DV of veteran’s final SBP control.   










Figure 4.  Data selection flow chart 
Data Analysis Procedure 
1. Screen for missing data with all IVs and DVs, including age, race, religion, 
tobacco use, alcohol use, OSA, DM, dyslipidemia, BMI, MDD, GAD, PTSD, 
medication adherence, brain damage, heart damage, kidney damage, A1C, HDL, 
number of BP med, number of clinic visits, baseline SBP, and final SBP.   
2. Screen for outliers (Mahalanobis distance).   
3. Determine if data transformation would be indicated.   
4. Run descriptive statistics on all IVs and DVs.  Show results by number and 
percentage with nominal, ordinal, or categorical level of data.  Show results by 
mean (M), standard deviation (SD), median, and mode for continuous levels of 
data. 
5. Test assumption of multiple linear regression (MLR) model and run the test.  
(1) Normality test: Histogram, box plots, skewness, kurtosis. 
(2) Linearity: Create correlation matrix between IVs and DVs (bivariate 
scatterplots). 
(3) Homoscedasticity: 
Record identified at Dash Board: 
N = 331 
N = 326 
4 Excluded (missing baseline SBP) 






(a) Tolerance statistics with all IVs’ indices < 0.1 indicates no 
multicollinearity problem (Mertler & Vannatta, 2013). 
(b) Variance inflation factor (VIF) for each predictor, where < 10 indicates no 
multicollinearity problem (Mertler & Vannatta, 2013). 
6. Major confounder of HTN control including BMI, Alcohol use, all medication 
and diagnosis of anxiety will be statistically controlled in this study.  
7. Test assumptions of LR model and run the test. 
(1) No normality, linearity, equal variance requirement. 
(2) Predictor variable can be continuous, scale, or dichotomous. 
(3) All probability will be ranging from 0 – 1. 
(4) Sensitive to multicollinearity relationships and outliers. 
(5) The -2 Log Likelihood (goodness of fit test) index should be = 0, but no strict 
adherence in LR statistical analysis (Mertler & Vannatta, 2013).   
8. Run χ2 or Fisher’s exact test to represent effect size with Cramer’s V for relevant 
variable associations with a 2 X 2 table. 
(1) Sample size assumption: no more than 20% of the contingency cells have 
expected values <5 (Blaikie, 2003). 
(2) Expected frequency cannot be <1 (Blaikie, 2003). 
(3) In case of assumptions will be violated, Fisher’s exact test would be used to 
interpret the test result as appropriately.    





9. Summarize and interpret the results, represents results with more tables or figures 
as indicated.   
10. Discuss the data analysis results with major limitations to the study.  
Protection of Human Subjects   
Informed consent was not needed as the study involved collecting information 
that had already existed in an EMR dashboard e-database and the research presented no 
more than a minimal risk of harm to the study subjects.  The protection of human subjects 
was ensured by the researcher throughout the study.  Prior to data collection, the 
researcher completed the National Institutes of Health (NIH) module on the protection of 
research subjects to have a thorough understanding of the methods used to protect 
research participants.  The activities of the researcher were monitored by the research 
committee chairperson.  The raw data will be stored in a password protected file on a 
thumbnail drive by the researcher for a minimum of five years after the publication of 













Chapter 4: Results 
Introduction 
The purpose of this study was to describe the multidimensional factors impacting 
veterans’ HTN control.  The purpose of this chapter was to present the overall results.  It 
begins with a data management brief, proceed to a description of the study results 
according to research aims and questions.  It concludes with a summary of the most 
significant result of the study.  
Data Management  
Prior to statistical analysis, the researcher reviewed inclusion and exclusion 
criteria and screened out five ineligible electronic medical records.  This resulted in a 
final sample size of 326.  Accuracy of the data was not randomly checked due to 
financial and time constraints during the data collection period.  Consequently, an 
interrater reliability of Cohen’s Kappa index was not calculated as originally planned.  
Since the researcher was the only person who has extracted data in a consistent manner, 
an intra-class correlation (ICC) would not be indicated.     
Description of the Study Results 
Aim # 1.   
Describe the characteristics of hypertensive veterans in one Southern California 






Question # 1.   
What were characteristics of hypertensive veterans in one Southern California VA 
clinic for the seven dimensions of IVs from data collected during a period of October 17, 
2014 through October 17, 2016? 
The study sample had most cases (80.4%) between the ages of 45 and 76 years 
old with Mage = 62 and SD = 13.  Most were male veterans (95.4%) diagnosed with 
essential HTN and comorbidities, including dyslipidemia (68.4%) with HDL level at 33 
mg/dl in most cases, obesity (56.7%) with BMI of 30 kg/m2 in most cases, and diabetes 
(45.4%) with A1C level at 5.5 mg/dl in most cases.  A large portion of cases (37.1%) had 
no service-connected disability rating, despite documented ratings for the remaining 
cases with M = 40% and SD = 40%.  Nearly one-half (47.9%) of cases were diagnosed 
with OSA, one-third (32.8%) with MDD, 20.9% with PTSD, and 12.9% with GAD.  
Most cases (70.9 %) were Christians, including 27% Roman Catholics and 43.9% non-
Catholic Christians.  Most cases (90.1%) served in either the U.S. Navy (63.1%) or U.S. 
Army (28.2%) during the Vietnam war/Korean war/World War II (47.6%).  Most cases 
did not use tobacco (79.4%) or consume alcohol (87.8%).  Approximately one-third of 
cases (36.5%) had an average of five to eight healthcare visits at a Southern California 
primary care or cardiology clinic, averaging two to four visits per year from October 17, 
2014 through October 17, 2016.  Most cases (42.6%) received only one antihypertensive 
medication with ACE inhibitors (38.3%), beta blockers (34.4%) and calcium channel 
blocker (30.7%) comprised the top three most commonly prescribed antihypertensive 





While rates of pre-HTN rose from 43.6% to 55.5%, Stage I HTN decreased from 30.4% 
to 16.3% during two-year study period.  Rates of Stage I HTN at baseline were 43.3%, at 
the final measurement were 21.2%, and the 2-year SBP control rate was 42%.  Tables 1-3 
provide a summary of the characteristics of HTN veterans in this Southern California 






Demographic Characteristics of Hypertensive Veterans in a Southern California Primary 
Care Clinic  
      N     % 
Age (in years) M = 62, SD = 13, Median = 63, Mode = 68 
     24 – 44 
     45 – 64 









Sex (Male) 311 95.4 
Race/Ethnicity (missing 14 = 4.3%) 
     Caucasian 
     African American  









Religion (missing 83 = 25.5%) 
     Roman Catholic 
     Non-Catholic Christians 









Branch of Military Service (missing 2 = 0.6%) 
     Air Force 
     Army 









Time Periods of Military Service 
     Peace Time Only 
     Persian Gulf War 









Education (missing 206 = 63.2%) 
     ≥ High School 












Medical History of Hypertensive Veterans in a Southern California Primary Care Clinic 
 N % 
Lifestyle      
 Current Tobacco Use 







Obstructive Sleep Apnea 156 47.9 
Comorbidity 
 Obesity (BMI ≥30) 
 BMI (kg/m2) M = 31, SD = 6, Median = 30, Mode = 30 
 Overweight (25 - 29.9) 
 Dyslipidemia  
 HDL (mg/dl) M = 43.8, SD = 15, Median = 40, Mode = 33 
  < 40 
  40 – 49 
  50 – 59 
  ≥ 60 
                          Missing 
 A1C (mg/dl) M = 6.3, SD = 1.3, Median = 6, Mode = 5.5 
   <6.5 
  6.5 – 8.4 
  ≥8.5 
  Missing 



































Mental Health Disorder 
 Major Depressive Disorder 
 Generalized Anxiety Disorder 









Target Organ Damage 
 Brain (stroke, transient ischemia attack) 
 Heart (heart failure, coronary artery disease, heart attack, CABG) 









Service-Connected Disability (%) M = 40, SD = 40, Median = 30 Mode = 0 
 No Disability Rating 
 10-50% Disability Rating 














Hypertensive-Related Data for Study Veterans in a Southern California Primary Care 
Clinic  
Parameter N % 
Medications 
     Self-Reported Medication Non-Adherence 
     Clinic visits (visit/2-year) M = 6, SD = 4, Median = 6, Mode = 5 
          0 visit in 2-year 
       1-4 visits in 2-year 
       5-8 visits in 2-year 
        ≥9 visits in 2-year 
     BP medication class (M = 1.6, SD = 1, Median = 1, Mode = 1) 
  0   BP RX 
  1   BP RX 
  2   BP RX 
  3+ BP RX 
     All medications (M = 8.56, SD = 4.6, Median = 8, Mode = 5) 
       1-5 medications 
       6-10 medications 
       11-15 medications 



































Baseline SBP (mmHg) M = 137, SD = 18, Median = 138, Mode = 138 
Final SBP (mmHg) M = 130, SD = 15, Median = 130, Mode = 132 
Baseline SBP (120-139 mmHg) 
Final SBP (120-139 mmHg) 

















Aim # 2.   
Examine the relationships among the predictor variables of blood glucose level 
(A1C), high-density lipoprotein (HDL), body mass index (BMI), number of BP 
medication prescribed, number of clinic visits, baseline SBP, and the outcome variable of 
the final point SBP. 
Question # 2a.   
Which of the possible six predictor variables were included in an equation for 
predicting veterans’ final point SBP?   
Answer # 2a.   
Prior to conducting a stepwise MLR analysis, data was screened for missing 
values and outliners.  The process led to an elimination of 25 outlier cases based on a 
Mahalanobis distance ≤ 22.458 at P <0.001.  Normality was assessed by visual inspection 
of histogram (see Figure # 5-8) and skewness, kurtosis per descriptive statistics (see 
Figure 9). This process led to transformation of four variables A1c, HDL, BMI, BaSBP.   
Homoscedasticity was accessed by tolerance statistics and VIF with all IV indices > 0.1 
and VIF indices < 10 (see Figure 10) and residual plots without major clusters (see 
Figure 11) indicated no homoscedasticity problems.  Linearity was assessed between IVs 
and DV with transformed data by scatter and residual plots (see Figure 12).  
Only one out of six predictor variables could be included in the prediction model.  
The other five (A1c, HDL, BMI, BP drug class and clinic visit) could not be included in 
the prediction model due to a severe violation to linearity assumption of the MLR model 





correlations between IVs and DV or disconnected scores from the center mean line 
without a rectangular formation on the residual plot (see Figure 11).   At this point, a 
decision was made to abandon the MLR analysis for a concern that forcing it may 
produce a false or biased result.   
Question # 2b.   
Does the obtained regression equation resulting from a subset of the six predictor 
variables allow us to reliably predict veterans’ final point SBP?   
Answer # 2b.   
After eliminating five predictor variables from the MLR equation, baseline SBP 
was the only predictor variable left in the prediction model and it did not allow us to 
























Figure 8.  Histogram baseline SBP 
Descriptive Statistics 
 A1c HDL BMI Baseline SBP 
N Valid 306 318 326 326 
Missing 20 8 0 0 
Mean 6.337 43.80 31.16 138.71 
Median 6.000 40.00 30.00 138.00 
Mode 5.5 33 30 138a 
Std. Deviation 1.3086 14.969 6.001 19.838 
Skewness 1.982 1.916 .914 .825 
Std. Error of Skewness .139 .137 .135 .135 
Kurtosis 4.961 7.203 1.164 1.861 
Std. Error of Kurtosis .278 .273 .269 .269 








95.0% CI for B Collinearity Statistics 
B Std. Error L. Bound U. Bound Tolerance VIF 
1 (Constant) -93.128 34.914 .008 -161.841 -24.415 >0.1 <10 
lg10A1c -3.073 10.961 .779 -24.645 18.499 .928 1.077 
lg10HDL 3.622 6.671 .588 -9.506 16.751 .853 1.173 
lg10BMI 15.819 10.757 .142 -5.352 36.990 .870 1.150 
lg10BaSBP 90.897 13.421 .000 64.485 117.309 .973 1.028 
BP drug class .784 .847 .355 -.883 2.452 .951 1.051 
Clinic Visit .100 .222 .652 -.337 .538 .960 1.041 
Figure 10.  Tolerance and VIF 
 








Figure 12.  Scatterplots for Question # 2a 
Aim # 3.   
Describe any significant association among non-normally distributed IVs and the 
final SBP.  
Question # 3.   
Can status of veterans’ final SBP be correctly predicted from knowledge age, 
A1C, HDL, BMI?   
Answer # 3.   
Since total BP med and clinic visit were normally distributed variables per 
histograms and descriptive statistics, they were not included in the LR model testing.  
Age was added to the LR model analysis instead. 
Forward stepwise LR analysis was conducted to explore which of the four (age, 





medication and anxiety statistically).  Regression results indicated that the overall model 
fit was good with -2 Log likelihood = 405.969 compared to -2 Log likelihood = 748.595 
capable of predicting membership reliably (Mertler & Vannatta, 2013).  However, none 
of the four IVs were entered at the step one of the forward LR model, indicated that there 
was not any significant correlation among them.    
Aim # 4.   
Describe any relationships between categorical predictor variables (Yes/No) and 
an outcome variable of final (SBP < 140) or (SBP ≥140).  
Question # 4.   
What were the significant relationships between age (≥60 or <60), race 
(Black/non-Black), religion (yes/no), tobacco use (yes/no), alcohol use (yes/no), OSA 
(yes/no), DM (yes/no), dyslipidemia (yes/no), BMI (≥30, <30), MDD (yes/no), GAD 
(yes/no), PTSD (yes/no), medication adherence (yes/no), brain damage (yes/no), heart 
damage (yes/no), CKD (yes/no) and final SBP (≥ 140, < 140)?  
Answer # 4.   
χ2 tests were conducted to determine any relationships between 15 nominal 
independent variables and the outcome variable.  There was a strong evidence  
(p < 0.001) to indicate that 1 of the 15 predictor variables (i.e., self-reported medication 






Relationships between Categorical Independent Variables and Final SBP  
Variable χ2 
Fisher’s Exact Test 
p Cramer’s V 
Age (≥60/<60) 0.002 .960 .003 
Race (Black/non-Black) 0.477 .490 .041 
Religion (yes/no)  0.651 .722 .047 
Tobacco use (yes/no) 0.004 .949 .004 
Alcohol use (yes/no) 0.168 .682 .024 
OSA (yes/no) 0.276 .600 .030 
DM (yes/no) 0.036 .850 .011 
BMI (≥30/<30) 1.058 .304 .059 
MDD (yes/no) 1.106 .303 .059 
GAD (yes/no) 0.013 .910 .007 
PTSD (yes/no) 0.052 .478 .122 
Med-adherence (yes/no) 80.921 < .001** .586 
Brain damage (yes/no) 1.495 .221 .070 
Heart damage (yes/no) 3.385 .066 .106 





Medication Adherence & Final SBP Chi-Square Tests 










Pearson Chi-Square 103.373a 2 .000 .000   
Likelihood Ratio 83.754 2 .000 .000   
Fisher's Exact Test 80.921   .000   
Linear-by-Linear 
Association 
21.868b 1 .000 .000 .000 .000 
N of Valid Cases 301      
a. 3 cells (50.0%) have expected count less than 5. The minimum expected count is 1.24. 
b. The standardized statistic is -4.676. 
Figure 13.  X2 test / Fisher’s exact test 
The X2 test result of medication adherence (yes/no) and SBP (≥140/<140) shows 
that 3 cells = 50% which is ≥20% have expected count less than 5 with a standardized 
statistic of -4.667 (<1), indicating an assumption violation.  Fisher’s exact test was used 
to interpret the test result.   






Nominal by Nominal Phi .586 .000 .000 
Cramer's V .586 .000 .000 
N of Valid Cases 301   
Figure 14.  Cramer’s V 
Summary of Results 
Utilizing a convenient sample of 331 cases to represent hypertensive veterans in 
the Southern California region, data was collected to explore multidimensional factors 





support that self-reported medication adherence to antihypertensive drugs was an 

























Chapter 5: Discussion  
The purpose of this chapter is to provide rich discussion to the study results.  It 
begins with a summary discussion of the research design and methodology that impact 
the study results.  It then compares these results with previous results in the area.  It next 
discusses the study limitations.  It ends with implications for future research and a 
conclusion.   
Summary of Research Design and Method 
This was the first study that utilized a VA dashboard data set in an EMR system 
to explore multidimensional factors impacting U.S. veterans’ final SBP.  The unique 
research design allowed the study to provide novel insights into multiple aspects of HTN 
control research results for future studies.  First, the descriptive statistics demonstrated a 
long term (2-year) uncontrolled SBP rate of 58% and an increased pre-HTN rate of 
11.9% from a baseline point 43.6% to a final point of 55.5% of an EMR review.  Second, 
the fitness test of exploratory MLR model showed five unfitted variables including A1C, 
HDL, BMI, BP med, clinic visit due to severe normality and or linearity violations.  The 
unfitting variable of A1C and HDL could be associated to manipulations by DM and 
dyslipidemia medication therapy, making values of A1C and HDL atypical.  The 
exploratory stepwise LR model showed a good overall model fit, no significant 
correlations were found between four IVs (i.e., age, A1C, HDL, Baseline SBP) and one 
DV (SBP), suggesting none of the four IVs from this data set were predictors for 
veterans’ final SBP.   Since A1C represents ones’ average blood sugar level within past 





have meaningful correlational outcomes.  However, that was not the case in this study.  
The exploratory χ2 tests showed 14 out of 15 non-significant associations between and 
among independent variables (i.e., OSA, DM, dyslipidemia, MDD, GAD, PTSD, brain 
damage, heart damage, CKD) and a dependent variable of final SBP.  This is likely 
associated with utilizing ICD-9-CM codes that only have “yes/no” options in operational 
definition of many multidimensional variables by nature of utilizing retrospective data.  
Surprisingly, the study found strong evidence (p < .001) of self-reported medication 
adherence as an independent predictor for veterans’ final SBP based on a positive Fisher 
exact test.  Third, the cross-sectional data collection took place at a single point in time 
per study case and the researcher could easily over or under estimate the results, 
particularly in the estimation of regularly changing medication data.  Fourth, the 
retrospective EMR review utilized pre-existing data for a research purpose that was 
unintended when the data was created.  Nevertheless, the study had to employ available 
data to answer four research questions by this inquiry.  In this case, the results were less 
robust than desired.   Finally, the non-probability sampling method disqualified the study 
for inferential statistics by design.  However, multiple parallel comparisons of 
characteristics of this study sample with characteristics of the previous study sample have 





Comparison of Study Results  
Aim # 1.   
Describe the characteristics of hypertensive veterans in one Southern California 
VA clinic from data collected during a period of October 17, 2014 through October 17, 
2016. 
Question # 1.   
What were characteristics of hypertensive veterans in one Southern California VA 
clinic for the seven dimensions of IVs from data collected during a period of October 17, 
2014 through October 17, 2016? 
Per HTN control conceptual framework (see Figure 2), the demographic 
dimension included age, sex, race, religion, branch of service, time of service, education, 
and disability rating.  The result of this study with Mage = 62 and SD = 13 was consistent 
with a previous study results that showed veterans of multiple states with Mage = 63.9 and 
SD = 13.2 (Fletcher et al., 2012) and a study result that showed non-veterans at a 
Southern Florida Family Clinic with Mage = 62 and SD = 13 (Koti & Roetzbeim, 2015).  
This study’s Mage was also consistent with the HTN-age prevalence in the United States 
based on an epidemiological study by Yoon, Fryar, and Carroll (2015).  Gender of this 
study with 95.4% male was consistent with several previous HTN studies among VA 
populations (Range 92% - 96%; Choma, Griffin, Kaltenbach, Greevy, & Rumine, 2012; 
Fletcher et al., 2012; Gosmanova, Lu et al., 2014; Gosmanova, Molnar et al., 2015).  
Results of race (61.3% Caucasian) was consistent with a previous HTN study 





was consistent with another previous HTN study result (Gosmanova, Molnar et al., 
2015).  However, education background of this study was missing in 64.7% of the cases; 
yet multiple similar HTN studies reported no such information.  Results of religion, 
branch of military service, time of military service, and service connected disability have 
become major strengths of this study as the combined information allowed for a more 
complete picture of veterans’ wellbeing from multiple perspectives.  Spiritually, this 
study shows 71% of cases were Christians, including 27% Roman Catholics and 43.9% 
non-Catholic Christians compared with 69% Christians in the United States (Religion, 
2016).  Socioeconomically, this study shows the plurality of cases (43.6%) were Vietnam 
veterans with most of whom were from lower working class backgrounds with three 
fourths had family incomes above the poverty level (Sobering Vietnam Vets as of April 
2016).  Functionally, this study shows 37% cases without any service-connected 
disability ratings compared with previous HTN studies that had no such information 
reported.  Results of multiple parallel comparisons indicated a well-represented 
demographic dimension with additional strengths to the study. 
Per HTN control conceptual framework (see Figure 2), the lifestyle dimension 
included tobacco use and alcohol abuse.  This study shows 20.6% current tobacco and 
13.2% current alcohol users, consistent with a previous study results with 22% self-
reported smoker and 11% positive screen for mild alcohol misuse by AUDIT-C 
(Rittmueller et al., 2015).  Results of the parallel comparison of two studies indicate a 





Per HTN control conceptual framework (see Figure 2), the secondary HTN 
dimension included an OSA diagnosis.  This study shows 47.9% OSA among studied 
cases compared with 29% of mild and 30% of moderate OSA among hypertensive non-
veterans’ cases in a primary care setting (Brostrom et al., 2012), indicating more veterans 
in the study than non-veterans in a previous HTN study suffered OSA.  Since OSA is 
associated with metabolic syndrome (Kong et al., 2016) with much higher prevalence 
rates of dyslipidemia, obesity, and insulin resistance rates among veterans (Fryar et al., 
2016), it is possible that veterans would have also experienced a much higher rate of 
OSA than civilian population.   The parallel comparison of two studies indicates a much 
higher OSA cases in the study compared with a previous study of civilian counterpart 
(Brostrom et al., 2012).   
OSA represents a common, treatable, metabolic syndrome significantly associated 
with obesity, dyslipidemia and insulin resistance (Kong et al., 2016).  One component of 
treatment for OSA is weight loss; therefore, perhaps the time has come to debate 
instituting a policy that holds patients accountable for their healthcare providers’ 
recommendations.  Specifically, this policy could detail healthcare providers’ rights in 
situations where the patient does not demonstrate efforts to lose weight, refuses to discuss 
weight loss options, or does not wear continuous positive airway pressure (CPAP) 
machine at night based on the treatment providers’ best judgement.  Current health policy 
lacks a balanced approach in the long-term management of OSA, emphasizing patients’ 





Per HTN control conceptual framework (see Figure 2), a total of three sets of 
major CVD comorbidities and lab values were included in the dimension.  The study 
shows 68.4% dyslipidemia which was higher compared with a previous HTN study 
results of 56.6% (Fryar et al., 2016).  This study shows 56.7% obesity which was also 
higher compared with a previous HTN study result of 41.2% (Fryar et al., 2016).  This 
study shows a median BMI of 30 compared with a previous HTN study result that 
showed median BMI of 28.2 to 31.5, depending on group assignment by age (Choma et 
al., 2012).  The study also shows 45.4% DM which is much higher compared with a 
previous HTN study result that showed 16.4% among male veterans in the U. S. from 
2009 to 2012 (Fryar et al., 2016).  Additionally, this study result shows median A1C of 6 
mg/dl compared with a previous HTN study result that showed median A1C 7.0-7.2 
mg/dl depending upon group assignments by age (Choma et al., 2012).  The parallel 
comparison of two studies indicates a well-represented sampling in cardiovascular 
comorbidities of HTN (dyslipidemia and obesity) with exception of DM as there were 
more DM cases in the study than in the previous study.  Cases of DM in this study were 
better controlled than cases in the previous study.  No parallel comparison study could be 
found for the HDL laboratory value in the literature.   
Per HTN control conceptual framework (see Figure 2), the mental health 
dimension included three mental health diagnosis.  This study shows 32.8% MDD which 
is consistent with a previous HTN study result that showed 32.5% (Wecht et al., 2016).  
This study shows 12.9% GAD which is much lower than the previous HTN study result 





consistent with a previous HTN study result that showed 20% (Wecht et al., 2016).  The 
parallel comparison of two studies indicates a well-represented sampling of mental health 
diagnosis in MDD and PTSD. 
Per HTN control conceptual framework (see Figure 2), the medication dimension 
included medication adherence, an average of two-year clinic visit, number of BP 
medication patients were receiving, top three BP medication prescription names and a 
mean overall prescription medications patients were receiving at the time of data 
collection.  This study shows a self-reported non-adherence rate of 7.4%, a much lower 
rate than a previous HTN study result that showed ≥ 20% medication non-adherence rate 
(Meddings et al., 2012).  The result of two-year primary and cardiology clinic visit M 
±SD = 6±4, averaging 3±2 per year is consistent with a previous HTN study result that 
showed M±SD = 4.5±2 (Koti & Roetzbeim, 2015).  This study shows 7.7% cases 
received no BP medication, 42.6% received one, 31.9% received two and 17.8% received 
three or more BP medications, consistent with a previous HTN study results that showed 
41.6% received one, 26.9% received dual and 15.9% received three or more BP 
medications (Vincze et al., 2008).  A trend of the highest percentage of cases receiving 
monotherapy might indicate that 42.6% cases of this study and 41.6% cases of the 
previous HTN study were being treated for stage 1 rather than stage 2 HTN per JNC-7 
HTN treatment guideline.  In addition, this study shows the top three commonly 
prescribed antihypertensive medications were ACE inhibitor 38.3%, beta blockers 34.4%, 
and calcium channel blockers 30.7% compared with a previous HTN study that showed 





hypotensive group (Wecht et al., 2016) vs. ACE inhibitor 35.5%, calcium channel 
blockers 29%, and diuretics 27.4% in an orthostatic hypertension group (Wecht et al., 
2016).  Nevertheless, BP drug class makes no difference in reducing CVD risks among 
hypertensive cases based on a credible systematic review and meta-analysis (Frethim et 
al., 2012).  However, JNC-7 recommended monotherapy with diuretic for most 
(Chobanian et al., 2003) without a sound of scientific evidence.  This study shows a 
bimodal (see Figure 15) distribution in the total number of overall medications with two 
peaks at 5 and 10 indicating most study cases took either 5 or 10 kinds of prescription 
medications per day, a phenomenon of polypharmacy.  Unfortunately, the bimodal shape 
of the total number of overall medications prevented the variable from participating in 
both MLR and LR analysis due to a concern that the data might bring about false or 
biased results.  However, a previous HTN study result that showed “a higher number of 
prescribed medication (sr2 = 0.06, t = 2.42, p <.05) and lower medication adherence (sr2 = 
0.07, t =-2.60, p <.05) were statistically significant determinants” of an increased SBP 
among Chinese American immigrants (Li, Wallhagen, & Froelicher, 2010).  Results of 
the parallel comparisons indicate a well-represented sampling in total number of clinic 
visit and BP medication, but not medication adherence and total number of an overall 







Figure 15.  Bimodal distribution 
Per HTN control conceptual framework (see Figure 2), the uncontrolled HTN 
dimension included baseline and final SBP as well as end-organ damage.  Despite seven- 
point mean SBP decrease from the baseline 58% to the final point of 42%, the study 
shows a lower long term (two-year) SBP control rate of 42% (see Table 1) compared 
with the HTN control rate of 61.2%, a goal set by the Healthy People 2020 (Gillespie & 
Hurvitz, 2013).  The study shows 11.9% increase in pre-HTN cases from a baseline 





JNC-7 highlighted that “pre-hypertensive individuals require health promoting 
lifestyle modifications to prevent the progressive rise in BP and cardiovascular disease” 
(Chobanian et al., 2003, p. xiv) because risk for CVD doubles in increments of 20/10 
mmHg beginning at 115/75 mmHg (Chobanian et al., 2003).  Nurse practitioners with the 
best training in health promotion and disease prevention are well positioned to provide 
counseling services to patients for lifestyle changes if deemed to be necessary.  However, 
literature indicates that healthcare providers are not reimbursed for time spent on 
addressing lifestyle issues in patients with pre-hypertension (Hernandez & Anderson, 
2012).  This problem needs to be resolved at the federal level to include these services in 
Medicare and Medicaid coverage.   
This study shows HTN-associated brain damage in 5.8% study cases compared 
with a previous HTN study results that showed 4.2% to 4.5% depending upon a BP 
treatment goal (“JATOS,” 2008), heart damage (17.5%) compared with the previous 
HTN study results (5.4% to 11.8%) depending upon levels of alcohol consumption 
(Rittmueller et al., 2015) and kidney damage (11%) compared with the JATOS Study 
Group results that showed 9.8% to 10% (2008) at a baseline.    
In summary, multiple parallel or non-parallel comparisons of this study’s 
characteristics with prior studies helps to determine an external validity of an overall 
research results.  Primarily, this study’s results could be generalizable to the target 
population of U.S. veterans given that the sample’s characteristics are highly 
representative of this group in terms of age, gender, ethnicity, lifestyle factors, 





Aim # 2.   
Examine the relationships among the predictor variables of blood glucose level 
(A1C), high-density lipoprotein (HDL), body mass index (BMI), total number of BP 
medication prescribed, total number of clinic visits, baseline SBP and the outcome 
variable of the final point SBP. 
Question # 2a.   
Which of the possible six predictor variables (i.e., A1C, HDL, BMI, clinic visit, 
BP med class, baseline SBP) were included in an equation for predicting veterans’ final 
point SBP?   
Question # 2b.   
Does the obtained regression equation resulting from a subset of the six predictor 
variables allow us to reliably predict veterans’ final point SBP?   
Five out of six predictor variables were excluded from the MLR model due to 
severe linearity violations to the model assumption.  As such, baseline SBP was the only 
predictor variable remaining in the MLR prediction model.  Since veterans’ SBP 
fluctuated throughout the day and can also be affected by confounders of lifestyle (e.g., 
alcohol, diet, exercise, caffeine, stress) and medication factors, a single baseline SBP 
would not have allowed us to predict veterans’ final SBP reliably as multiple confounders 
were unaccounted by the prediction model.  There are other factors that could have 
impacted A1C’s model fitness.  First, A1C values lack variance when most (64.1%) DM 
cases were well controlled by medication therapy as evidenced by A1C mode = 5.5 mg/dl 





violation to the MLR model assumption.  Second, A1C represents an average of blood 
sugar level in the past three months and it must be associated with final SBP 
measurements within the same time periods for a meaningful outcome.  However, that 
was not the case in this study.   
While there is no evidence of a study examining an association between HDL and 
SBP in the literature, this study failed to find any association between the two variables.  
Nevertheless, HDL mode = 33 mg/dl was well below the normal values of ≥ 40 mg/dl for 
men and ≥ 50 mg/dl for women, this could indicate that HDL values are difficult to 
change with or without medication therapy.  Moreover, HDL Kurtosis = 7.203 was unfit 
to a normal bell curve due to a severe violation to MLR model assumption.  The non-
linear association between HDL and SBP based on scatter plots (see Figure 12) was 
another violation to MLR model assumption.  Although no evidence of a study 
examining the association, a previous HTN study found a positive association (p < 0.01) 
between the ratio of total cholesterol (TC) to HDL or TC/HDL and BP alternatively 
(Okosun, Choi, Hash, & Dever, 2001).   
While no evidence of a study examining an association between number of clinic 
visits and SBP, this study failed to detect any association between the two variables due 
to a severe violation of linearity assumption to the MLR model.  While a previous 
systematic review and meta-analysis found no significant differences between BP 
medication class and BP reduction for primary prevention of DVD (Frethim et al., 2012),  
this study failed to detect any association between the two variables due to a severe 





Aim # 3.   
Describe any significant association between and among non-normally distributed 
IVs and the final SBP. 
Question # 3.   
Can status of veterans’ final SBP be correctly predicted from knowledge of age, 
A1C, HDL, BMI?   
Considering the review of relevant literature that found no statistically significant 
association between age and SBP, this study failed to detect it despite a previous 
epidemiology study showing an evidence that a relationship between age and SBP did 
exist (Yoon et al., 2015).   Considering a previous systematic review and meta-analysis 
which found a weak linear association between BMI and SBP (Abayomi, 2012), this 
study failed to detect it in a LR model analysis.  Failing to detect BMI and SBP 
association could be attributed to the strength of R2 values that ranged from 0.083 (weak) 
for males to 0.203 (weak) for females in the meta-analysis (Abayomi, 2012) with a good 
overall LR model fit background.  Although weak associations could be detected with a 
high power by increasing a sample size, it was not the case in this study.   
Aim # 4.   
Describe any relationships between categorical predictor variables (Yes/No) and 
an outcome variable of final controlled (SBP < 140) or uncontrolled (SBP ≥140).  
Question # 4.   
What were the significant relationships between age (≥60 or <60), race 





(yes/no), DM (yes/no), dyslipidemia (yes/no), BMI (≥30, <30), MDD (yes/no), GAD 
(yes/no), PTSD (yes/no), medication adherence (yes/no), brain damage (yes/no), heart 
damage (yes/no), CKD (yes/no) and final SBP (≥ 140, <140)?  
This study shows a strong evidence (P<0.001) that self-reported medication 
adherence is an independent predictor for veterans’ SBP.  These results support a 
previous HTN study that showed habit-based medication adherence was not only the 
most effective predictor for BP outcomes, but also the most effective intervention in 
reducing BP by a systematic review and meta-analysis (Con, Ruppar, & Chase, 2016).      
Although age 60 is a cut off point for a new set of BP treatment goals per JNC-8 
(James et al., 2013), this study shows no significant association between age (≥60 / <60) 
and SBP (≥ 140 / <140).  Still, 60 seem to be an age of high HTN prevalence in multiple 
epidemiology studies.  However, it is the inferential statistics showing a statistically 
significant association between age and SBP with a p-value (<0.05) that matters.  So far, 
there is no previous study with a finding of a significant association between age and BP 
in the literature.     
This study shows no significant association between race (black / non-black) and 
SBP (≥ 140 / <140), inconsistent with a previous systematic review that showed a small 
effect size, but significant association between perceived racial discrimination among 
hypertensive black males with low education level and HTN (Dolezsar, McGrath, Herzig, 





This study shows no significant association between religion (yes / no) and SBP 
(≥ 140 / <140) compared with a previous study that showed religious service attendance 
is inversely associated to SBP among white, black and Mexican-American ethnic groups 
(Bell et al., 2012). There is no systematic review and or meta-analysis exploring a 
relationship between religious involvement and SBP to the best of my knowledge.    
This study shows no significant association between tobacco use (yes / no) and 
SBP (≥ 140 / <140), consistent with a previous cross-sectional study that showed 
tobacco use had no effect on BP (Li et al., 2010; Pandey et al., 2014; Thuy et al., 2010).   
However, there is no systematic review and or meta-analysis exploring an association 
between tobacco use and SBP to the best of my knowledge.    
This study shows no association between alcohol use (yes / no) and SBP (≥ 140, 
<140) compared with a previous systematic review and meta-analysis that showed an 
association between dose-response alcohol consumption and risk of HTN (Briasoulis et 
al., 2012).  Specifically, drinking alcohol <10 gm/day to 11-20 gm/day has a trend toward 
an increased risk of HTN (RR 1.03, 95% CI, 0.94 -1.13, p = 0.51) and (RR 1.15, 95% CI, 
0.99-1.33, p = 0.06) respectively, and that men with heavy drinking of alcohol at 31- 40 
gm/day is significantly associated with an increased risk of HTN (RR 1.77, 95% CI, 1.39-
2.26, P<0.001).  However, that systematic review and meta-analysis demonstrated an 
inclusion of articles defining HTN as BP ≥ 165/95 mmHg rather BP ≥ 140/90 mmHg, 





This study shows no association between OSA (ye s/ no) and SBP (≥ 140 / 
<140), consistent with a reviewing of relevant literature that found no association 
between OSA and BP by systematic review and or meta-analysis to the best of my 
knowledge.   
This study shows no association between DM (yes / no) and SBP (≥ 140 / <140), 
consistent with a review of relevant literature that found no association between DM and 
BP by systematic review and or meta-analysis to the best of my knowledge. 
This study shows no association between dyslipidemia (yes / no) and SBP (≥ 140 
/ <140), consistent with a review of relevant literature that found no association between 
dyslipidemia and BP by systematic review and or meta-analysis to the best of my 
knowledge. 
This study shows no association between BMI (≥30 / <30) and SBP (≥ 140 / 
<140), inconsistent with findings from two previous HTN studies that showed BMI was 
not only significantly and positively associated with SBP and DBP (Zhang, Wang, Yan, 
Gong, & Guo, 2013), but also linearly or curvilinearly associated with SBP by a meta-
analysis despite the relationship was rather weak (Abayomi, 2012).   
This study shows no association between MDD (yes / no) and SBP (≥ 140 / 
<140), consistent with a review of relevant literature that found no association between a 
diagnosis of MDD and SBP to the best of my knowledge.   
This study shows no association between GAD (yes / no) and SBP (≥ 140 / 





showed a significant association between anxiety and HTN with OR 1.18, 95% CI, 1.02 
to 1.37, P < 0.001 (Pan et al., 2015).   
This study shows no association between PTSD (yes / no) and SBP (≥ 140 / 
<140), consistent with a review of relevant literature that found no association between 
PTSD diagnosis and SBP to the best of my knowledge. 
This study shows a strong evidence (P<0.001) of self-reported medication 
adherence to antihypertensive medication (yes / no) and is an independent predictor to 
veterans’ SBP (≥ 140 / <140), inconsistent with a review of relevant literature that found   
no systematic review and or meta-analysis exploring such a relationship to the best of my 
knowledge.  Therefore, the finding of such a significant association could be viewed as 
innovative and the result must be confirmed by systematic review and or meta-analysis 
utilizing RCT and longitudinal studies in the future.  However, current medication 
adherence construct lacks an association with BP control outcome which makes it 
difficult to associate two variables of medication adherence and BP in one entity.  
Clearly, there is a need for an operational definition of patients’ adherence to 
antihypertensive medication that are associated with BP outcomes in one entity.     
Finally, this study shows no association between brain damage (yes / no), or heart 
damage (yes / no) or kidney damage (yes / no) and SBP (≥ 140 / <140), inconsistent 
with two previous Japanese study results that showed brain damage, or heart damage or 
kidney damage were significantly associated with SBP (“JATOS,” 2008; Ogihara et al., 





would be better if evidence of significant associations between and among brain, heart, 
kidney damages and SBP were found from a couple of systematic review and or meta-
analysis, however such evidence was not found by this review of relevant literature.   
Comparing this study results that utilized MLR, LR and X2 statistical analysis 
models with previous HTN study results via systematic review and or meta-analysis may 
seem to be unparalleled.  However, this is the best way for truth finding if researchers 
want the most efficient way about it.  First, systematic review and or meta-analysis are 
research designs with the highest level of study quality (Crowther, Lim, & Crowther, 
2010).  Second, systematic review and or meta-analysis produces results with less biases 
(Crowther et al., 2010) compared with results from cross-sectional studies.   
Limitation  
There are several limitations to this study.  First, there were noteworthy issues 
with the operational definition of key study variables including A1C, tobacco 
dependence, alcohol abuse or misuse, MDD, GAD, PTSD, OSA, DM, dyslipidemia, 
Obesity, CVA, TIA, CHF, CAD, MI, CABG and CKD, resulting in an inadequate 
assessment of correlations between these variables and final SBP.  Future studies should 
pay attention to the special features of A1C values and consider using validated 
multidimensional instruments in relationship studies.  Specifically, ensuring A1c values 
matches BP measurements within three-months window time frame for meaningful 
correlational outcomes is important.  Moreover, using patients’ Health Questionnaire 
(PHQ-9; Kroenke, Spitzer, & Williams, 2001) for assessing MDD, Generalized Anxiety 





PCL-5-M (Keane et al., 2014) for PTSD are more meaningful than using ICD-9-CM 
codes with “yes / no” operational definition in relevant relationship studies.  Second, 
there were major barriers to data accuracy assessment regarding primary data 
manipulation and data collection.  Specifically, primary data of A1C and HDL values 
were manipulated by medication therapy for approximately 96.3% veterans and the 
impact of manipulation to the overall statistical model fit was difficult to estimate.   
Additionally, funding and time constraints prohibited random check blindly on collected 
data.  Consequently, the inter-rater agreement Kappa was not calculated to confirm the 
accuracy of the data collected.   
Implication for Future Research  
Although this study finds self-reported medication adherence is an independent 
predictor to a veteran’s final SBP level, validity of self-reported medication adherence 
can be influenced by multidimensional factors including patients-related factors (e.g., 
age, sex, race, education level, knowledge, self-care ability, patient-satisfaction, self-
efficacy, attitude, cognition, perceived stress), provider-related factors (e.g., prescription 
of medication, communication style, attitude toward adhering to current HTN treatment 
guideline, role modeling, teaching consistency and content) and environment-related 
factors including health policy (e.g., insurance, copayment, BP treatment goal per HTN 
management guideline) and healthcare system (e.g., access to care, communication 
system) (Viswanathan et al., September 2012).  Therefore, future HTN control research 
should focus on multidimensional determinants of self-reported patients’ adherence to 





that some patients are not on antihypertensive medication therapy for treatment of HTN 
and that lifestyle modification works for BP reduction (Briasoulis et al., 2012; 
Landsbergis et al., 2013; Mesas, Leon-Munoz, Rodriguez-Artalejo, & Lopez-Garcia, 
2011; Saneei et al., 2014; Semlitsch et al., 2013), future HTN research should focus on 
multidimensional determinants of self-reported patients’ adherence to HTN treatment 
fully  to broaden the scope of coverage.   Since current definition of patients’ adherence 
to HTN treatment lacks an association with HTN outcomes based on extensive review of 
relevant literature, future HTN control research should focus on operationally defining 
adherence and BP control outcomes in one entity.   Since HTN definition can affect HTN 
control outcomes, future HTN control study should use a consistent HTN definition 
defined by JNC-7 rather than JNC-8.   Since self-reported HTN treatment may be 
influenced by not only patients, but also healthcare providers, future HTN control studies 
should assess this construct for both patients and healthcare providers simultaneously so 
that two-way outcome feedback could be accomplished.  Since theory can help to make 
predictions of ones’ BP levels possible (Bandura, 1971) when an operational definition of 
patients’ adherence to HTN treatment is defined with BP outcome in one entity, future 
HTN control research should focus on some theory-guided operational definitions linking 
patients’ adherence to HTN treatment and outcomes (e.g., primary, secondary and or 
tertiary).   
Ideally, patients’ adherence to HTN treatment should be assessed by a scaled 
measure that takes into consideration multidimensional factors impacting BP control 





easily done in the real world.  However, it may subject veterans’ to recall bias and 
reading level.  Therefore, future theory guided operational definitions of self-reported 
adherence to HTN treatment will be challenged by these limitations.  It is therefore, 
vitally important to consider using the future tense in the sentence construction and 
reading level with some theory-guided operational definitions linking patients’ and 
providers’ adherence to HTN treatment and outcomes.  Multiple field tests and pilot 
studies would be necessary in the process of developing a reliable theory-guided 
instrument measuring self-reported patients’ and providers’ adherence to a standardized 
HTN treatment protocol in the future.    
Since the rate of pre-HTN increased from the baseline to final point per EMR 
review, associating risks of pre-HTN with CVD or benefit with pre-HTN could also 
guide future research.  Since current research is not only limited on the topic, but also 
with multiple methodological weaknesses in the research design based on a review of 
relevant literature, utilizing a random sampling method in longitudinal studies to explore 
any relationships would be helpful in contributing potential new knowledge to the 
existing nursing research database.      
Conclusion 
The study explored multidimensional factors impacting veterans’ HTN control 
with a descriptive, exploratory, cross-sectional, retrospective and non-probability 
sampling design.  Despite the limited data in essential areas, the study found a strong 
evidence (p<0.001) through fisher exact test to support that self-reported medication 





veterans’ final SBP.  Future HTN control research may focus on exploring some theory-
guided multidimensional determinants of patients’ and providers’ adherence to HTN 
treatments (e.g., lifestyle modification and antihypertensive drug therapy), rather than 
unidimensional medication adherence, and HTN control outcomes fully (e.g., BP, quality 
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Appendix A: SPSS Code for  
Exploring Factors Impacting Veterans’ Hypertension Control  
 
Variable  Variable Description Measure Values 
1. Age Index date per EMR review 




1 = 24 – 44,  
2 = 45 – 64,  
3 = 65+   
2. DisRat Disability rating by 





0 = 0 %,  
1 = 10 - 50%,    
2 = 60 - 100%,  




0 = < 6.5,  
1 = 6.5 – 7.4 
2 = 7.5 – 8.4,  
3 = 8.5 -9.4 
4 = ≥ 9.5,  
99 = missing 




1 = < 40,  
2 = 40-49 
3 = 50-59,  
4 = ≥ 60 
999= missing 




0 = 18.5-24.9,  
1 = 25.0-29.9 
2 = 30.0-34.9,  
3 = 35.0-39.9 
4 = ≥ 40.0 
6. BPRX 
 
Total number of BP 
medication prescription at 





0 = 0 BP RX  
1 = 1 BP RX 
2 = 2 BP RX 
3 = ≥ 3 BP RX 




1 = 1-5 pills 
2 = 6-10 pills 
3 = 11-15 pills 
4 = ≥16 pills 
8. ClinVist 
 
Total number of primary & 




0 = 0 visit in 2-year 
1 = 1-4 visits in 2-year 





during the 2-year study 
period 
 3 = ≥ 9 visits in 2-year 
9. BaSBP 
 
Baseline systolic BP at the 





0 = < 120,  
1 = 120-139  
2 = 140-159,  
3 = ≥160 
10. BaDBP Baseline diastolic BP at the 





0 = < 80,  
1 = 80-89  
2 = 90-99,  
3 = ≥100 
11. FiSBP Final systolic BP at the time 





0 = < 120,  
1 = 120-139  
2 = 140-159,  
3 = ≥160 
12. FiDBP Final diastolic BP at the 





0 = < 80,  
1 = 80-89  
2 = 90-99,  
3 = ≥100 
13. Sex Men or Women Nominal 1 = Men,  
2 = Women 
14. Race Race/Ethnicity of case Nominal 1 = Caucasian  
2 = African American  
3 = Other or missing   




1 = Roman Catholic 
2 = Non-Catholic Christian 
3 = other or missing   
16. Branch Branch of military serviced Nominal 1 = Air Force,  
2 = Army 
3 = Navy 
17. Time Time periods of service Nominal 0 = Peace time only 
1 = Persian Gulf War 
2 =Vietnam Era/Korean 
war/WW II 
18. Edu Highest education level 
attained 
Ordinal 1 = < High School,  
2 = ≥ High School,  
99 = missing 
19. Tobacco current smoke/chew tobacco 
per MD’s note/ICD-9-CM 
code 
Nominal  0 = no 





20. Alcohol current drink alcohol per 
ICD-9-CM code & MD’s 
note 
Nominal 0 = no 
1 = yes 
21. MDD MDD per ICD-9-CM code Nominal 0 = no, 1 = yes 
22. GAD GAD per ICD-9-CM code Nominal 0 = no, 1 = yes 
23. PTSD PTSD per ICD-9-CM code Nominal 0 = no, 1 = yes 
24. OSA OSA per ICD-9-CM code Nominal 0 = no, 1 = yes 
25. ACEI ACE inhibitor  Nominal  1 = Yes, 0 = No 
26. ARB Angiotensin Receptor 
Blocker  
Nominal 1 = Yes, 0 = No 
27. α-block α-blocker (Prazosin)  Nominal 1 = Yes, 0 = No 
28. BB BB (Atenolol)  Nominal 1 = Yes, 0 = No 
29. CCB CCB (Amlodipine, 
diltiazem, Verapamil, 
Nifedipine)  
Nominal 1 = Yes, 0 = No 
30. CAαA Centrally acting α-Agonist  Nominal 1 = Yes, 0 = No 
31. ComDrug Combination drugs  Nominal 1 = Yes, 0 = No 
32. Diuretic Diuretic  Nominal 1 = Yes, 0 = No 
33. HydraZin Vasodilator/hydralazine  Nominal 1 = Yes, 0 = No 
34. Spiro Spironolactone  Nominal 1 = Yes, 0 = No 
35. Iso Nitrates/Isosorbide  Nominal 1 = Yes, 0 = No 
36. MedAdh Medication adherence Nominal  0 = Medication Non-
adherence 
1 = Medication Adherence 
99 = missing  
37. EOD-brain EOD-brain: 
TIA/CVA/dementia 
Nominal 0 = no, 1 = yes 
38. EOD-heart EOD-heart 
CHF/CAD/MI/CABG 
Nominal 0 = no, 1 = yes 
39. EOD-
kidney 
Chronic kidney disease 
(CKD) 
Nominal 0 = no, 1 = yes 
40. Dyslip Dyslipidemia Nominal 0 = no, 1 = yes 
41. DM HTN comorbidity of DM Nominal 0 = no, 1 = yes 
42. FinalSBP For LR analysis Dichotomous 0 =≥ 140 
1 = < 140 
43. FinalDBP For LR analysis Dichotomous 0 = ≥ 90 





Appendix B: Data Abstraction Instrument (Microsoft Excel in Word Format) 
 
 1 2 3 4 5 6 7 
ID Age DisRat A1C HDL BMI BPmT AmT 
A0097,RIC        
 
 8 9 10 11 12 13 14 
ID ClinVist BaSBP BaDBP FiSBP FiDBP Sex Race 
B0245,ROG        
 
 15 16 17 18 19 20 21 
ID Religion Branch Time Edu Tobacco Alcohol MDD 
C0051,ROC        
 
 22 23 24 25 26 27 28 
ID GAD PTSD OSA ACEI ARB a-Block BB 
D0583,LAR        
 
 29 30 31 32 33 34 35 
ID CCB CAaA CombDrug Diuretic HydroZin Spiro Iso 
E1605,LIS        
 
 36 37 38 39 40 41 42 
ID MedAdhe EODbrain EODheart EODkidney Dyslip Obesity DM 






Appendix C: Theoretical and Operational Definition of Key Study Concept 
Age: is defined by the date of birth (DOB) on the day of an EMR review.   
Sex: is categorized by male or female per EMR review. 
Race/ethnicity: is classified as Caucasian, African American, Other or missing per EMR 
review. 
Religion: is classified by Roman Catholic, non-Catholic Christian, Other or missing per 
EMR review. 
Branch of military service: is classified as Air Force, Army or Navy per EMR review. 
Time periods of military service: is classified as Peace time only, Persian Gulf war, 
Vietnam Era / Korean war / WW II per EMR review. 
Education: is classified as ≥ high school or missing or < high school based on 
multidisciplinary “note” per EMR review. 
Service connected disability: is operationally measured from 0 to 100% per EMR 
review.   
Current tobacco use: is operationally measured by presence (yes) or absence (no) of 
tobacco dependence ICD-9-CM code 305.1 and primary healthcare providers’ “note” 
indicating current use per EMR review. 
Current alcohol use: is operationally measured by presence (yes) and absence (no) of 
alcohol abuse ICD-9-CM code 305.00 and primary healthcare providers’ “note” 
indicating current consumption of alcohol per EMR review. 
OSA: is operationally measured by presence (yes) or absence (no) of OSA ICD-9-CM 





DM: including type I and II, is operationally measured by presence (yes) or absence (no) 
of DM ICD-9-CM code 250.00 per EMR review.  
A1C: referring to an average blood sugar level for the past three months, is operationally 
measured by the latest (toward the end of a EMR review) A1C (mg/dl) value from 
October 17, 2014 through October 17, 2016 per EMR review. 
HDL: referring to a high-density lipoprotein level, is operationally measured by the latest 
(toward the end of chart review) HDL value (mg/dl) from October 17, 2014 through 
October 17, 2016 per EMR review. 
Dyslipidemia: referring to an abnormal blood lipid level, is operationally measured by 
presence (yes) or absence (no) of dyslipidemia ICD-9-CM code 272.4 per EMR review. 
BMI (body mass index): is operationally measured by the latest measurement (toward 
the end) from Oct 17, 2014 through Oct 17, 2016 per EMR review. 
MDD (major depressive disorder): is operationally measured by presence (yes) or 
absence (no) of MDD ICD-9-CM code 298.0 per EMR review. 
GAD (generalized anxiety disorder): is operationally measured by presence (yes) or 
absence (no) of GAD ICD-9-CM code 300.02 per EMR review. 
PTSD (post-traumatic stress disorder): is operationally measured by presence (yes) or 
absence (no) of PTSD ICD-9-CM code 309.81 per EMR review. 
BP medication: is operationally measured by a numeric number from 0 – 4 of BP 
medication class among ACEI, ARB, α-blocker, β-blocker, CCB, centrally acting α-
agonist, Combination drug, Diuretic, Vasodilator, Spironolactone and Nitrates case per 





Clinic Visit: is operationally measured by a numeric number from 0 – 15 primary care 
and cardiology clinic visits during a period of October 17, 2014 and October 17, 2016 
based upon the total number of BP measurements generated from those office visits. 
Baseline and final BP measurement: are continuous variable in “mmHg” by toward the 
beginning and toward the end of the EMR review from October 17, 2014 through 
October 17, 2016.   
Essential HTN: is operationally defined as BP elevation without identifiable cause with 
seated BP ≥ 140/90 mmHg at two or more office visits or current use of BP-lowering 
medication with ICD-9-CM code of 401 regardless their awareness of it (Chobanian et 
al., 2003; James et al., 2013). 
Controlled HTN: is operationally defined as BP < 140/90 mmHg at both the baseline 
and the final points of a EMR review. 
Uncontrolled HTN: is operationally defined as BP ≥ 140/90 mmHg at both the baseline 
and the final points of a EMR review. 
Medication adherence: is operationally measured by primary healthcare providers’ note 
(e.g., patient was non-adherent to antihypertensive drug therapy, or patient refused to 
antihypertensive drug therapy) per EMR review.   
End organ damage of brain: is operationally measured by presence (yes) or absence 
(no) of TIA, CVA and dementia ICD-9-CM code of 433.1 for TIA, 434.91 for CVA and 





End organ damage of heart: is operationally measured by presence (yes) or absence 
(no) of CHF CAD, MI, CABG ICD-9-CM codes of 428.0 for CHF, 414.01 for CAD, 
410.9 for MI and V45.81 for CABG per EMR review.  
End organ damage of kidney: is operationally measured by presence (yes) or absence 
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